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ABSTRACT 
 
Matthew W. Haley 
Efforts Towards the Total Synthesis of (+)-Sorangicin A 
(Under the direction of Michael T. Crimmins) 
 
Efforts towards (+)-sorangicin A, a previously unprepared antibiotic 
macrolide, are reported.  A modular approach which investigates several 
coupling strategies for the union of three core cyclic ether fragments was utilized.  
The bicyclic ether and tetrahydropyran moieties were constructed utilizing a ring-
closing/epoxide opening strategy while the dihydropyran subunit relied on a ring-
closing metathesis for the formation of the heterocycle.  The three core synthetic 
fragments were elaborated to various synthetic intermediates and several 
coupling strategies were evaluated. 
 
 
 
  
iv 
 
ACKNOWLEDGEMENTS 
 
I first must thank Professor Crimmins for being an ideal advisor.  His door 
was always open, his approach was always patient, and his advice was always 
wise.  I am truly grateful.   
Over the course of my graduate career I interacted with several chemists 
that selflessly contributed to making me who I am as a scientist and also to 
creating a fantastic work environment.  Dr. Theo Martinot took me under his wing 
when I first started in lab and essentially taught me how to do chemistry.  I will 
forever be indebted to him for his advice and friendship.  Dr. Mike Ellis deserves 
special thanks for the discussions we’ve had and the advice he gave both while 
at UNC and afterwards as well as his friendship.  Dr. Patrick McDougall also 
went far beyond the call of duty as he offered invaluable advice and guidance 
both while at UNC and after.  Dr. Anita Mattson provided a helpful source of 
discussion and advice as the only Crimmins postdoc for almost a year, which 
was my last at UNC, and in that time Anne-Marie Dechert provided a friendship 
that made lab an enjoyable place to be.  Dr. Danielle Jacobs has proofread 
nearly everything I have written pertaining to chemistry, I am grateful for all the 
effort and her friendship.  The completion of my thesis was also assisted by 
Dieter Weber who kindly translated publications for me on short notice.  
v 
 
My time at UNC has also given me the opportunity to develop friendships 
that let me escape the workplace.  Dr. Matthew Campbell, Miranda Welsh, Dr. 
Ben Pierce, Josh Sokal and especially Liz Cline have made the time I have spent 
at UNC truly enjoyable.  I also would like to acknowledge those who contributed 
to the inception of the UNC boxing team: Dan, Frank, Travis, and Professor 
Kropp.  Coaching taught me at least as much as I learned between the walls 
Kenan Labs.   
Finally, I would like to thank my family.  My brother AJ and my sister Mary 
have made me proud and inspired me more than they know.  And I would like to 
thank my Mom and Dad for every opportunity they have given me and the 
unwavering confidence that they have in me. 
vi 
 
Table of Contents 
 
List of Tables ............................................................................................ viii 
List of Figures ............................................................................................ ix 
List of Schemes .......................................................................................... x 
List of Abbreviations ................................................................................ xvii 
Chapter 
1. Background Information and Reported Synthetic Efforts ........... 1 
1.1 Isolation .............................................................................. 1 
1.2 Structural Elucidation ......................................................... 2 
1.3 Biogenesis .......................................................................... 3 
1.4 Biological Activity................................................................ 3 
1.5 Published Synthetic Efforts ................................................ 4 
1.5.1 Synthetic Efforts Reported by Smith .......................... 4 
1.5.1.1 1st Generation Synthesis of the  
Bicyclic Ether Fragment .................................. 5 
1.5.1.2 2nd Generation Synthesis of the 
Bicyclic Ether Fragment .................................. 9 
1.5.1.3 Synthesis of the THP Fragment .................... 12 
vii 
 
1.5.1.4 Synthesis of the DHP Fragment .................... 14 
1.5.2 Synthetic Efforts Reported by Schinzer.................... 17 
1.5.2.1 Synthesis of the Bicyclic Ether and THP 
Fragments from One Synthetic  
Intermediate .................................................. 18 
1.5.2.2 Synthesis of the DHP and Side 
Chain Fragments ........................................... 21 
1.5.3 Synthetic Efforts Reported by Lee ........................... 22 
1.6 References ....................................................................... 26 
2. Synthesis of the Core Synthetic Fragments ............................. 33 
2.1 Synthetic Strategy ............................................................ 33 
2.2 Synthesis of the Bicyclic Ether Fragment ......................... 35 
2.2.1 Synthetic Strategy .................................................... 35 
2.2.2 Synthesis of the Cyclization Precursor ..................... 36 
2.2.3 Bicycle Formation .................................................... 40 
2.2.4 Structure Determination and Completion ................. 41 
2.3 Synthesis of the THP Fragment ....................................... 43 
2.3.1 Similarity between the THP and Bicyclic 
Ether Fragments ...................................................... 43 
2.3.2 Synthetic Strategy .................................................... 44 
2.3.3 Synthesis of the Cyclization Precursor ..................... 45 
2.3.4 THP Formation ......................................................... 47 
2.3.5 Elaboration of the THP ............................................. 48 
2.3.6 Structure Determination ........................................... 51 
2.4 Synthesis of the DHP Fragment ....................................... 52 
viii 
 
2.4.1 Synthetic Strategy .................................................... 52 
2.4.2 Synthesis of the RCM Precursor .............................. 53 
2.4.3 DHP Formation ........................................................ 54 
2.4.4 Structure Determination ........................................... 57 
2.4.5 Elaboration ............................................................... 57 
2.5 Summary .......................................................................... 62 
2.6 References ....................................................................... 64 
3. Coupling Strategies .................................................................. 68 
3.1 Synthetic Strategy ............................................................ 68 
3.2 Coupling the Bicyclic Ether and THP Fragments ............. 70 
3.2.1 1st Generation Cross Metathesis .............................. 70 
3.2.2 2nd Generation Cross Metathesis ............................. 72 
3.3 Coupling Strategies Following Path A .............................. 72 
3.3.1 Acetylide Addition .................................................... 73 
3.3.2 Cross Metathesis ..................................................... 77 
3.4 A Coupling Strategy Following Path B .............................. 84 
3.5 Summary .......................................................................... 88 
3.6 Future Direction ................................................................ 91 
3.7 References ....................................................................... 93 
4. Experimental ............................................................................ 95 
4.1 Materials and Methods ..................................................... 95 
4.2 Procedures ....................................................................... 96 
4.3 1H and 13C NMR Spectra ................................................ 143 
ix 
 
List of Tables 
 
2.1 Cross Metathesis Conditions for Olefin 125 with Ethyl Acrylate ............... 39 
2.2 Cross Metathesis Conditions for Aldol Adducts 142 and 143 ................... 46 
2.3 Allylation Conditions for Mixed Acetal 157 ............................................... 56 
 
 
 
 
 
 
 
 
 
 
 
 
x 
 
List of Figures 
 
1.1  (+)-Sorangicin A…………………………………………………………………1 
1.2 X-Ray Crystallographic Data for (+)-Sorangicin A as  
Reported by Jansen ................................................................................... 2 
2.1 Conformations for the 6-exo and 5-endo Epoxide Openings  
of Diol 110 ................................................................................................ 36 
2.2  X-ray Crystallographic Data for p-Nitrobenzoate 131……………….……..42 
2.3 Stereochemical Configuration Confirmation of THP 150 
  via nOe Analysis ...................................................................................... 51 
2.4 Stereochemical Configuration Confirmation of DHP 106  
via nOe Analysis ...................................................................................... 57 
3.1 Determination of the C-21 Stereochemical Configuration  
of Alkyne 208 ........................................................................................... 80 
 
 
 
 
 
xi 
 
List of Schemes 
 
1.1 Three Synthetic Fragments of (+)-Sorangicin A  
as Reported by Smith ................................................................................. 5 
1.2 Bicyclic Ether Fragment 2 and Key Retrosynthetic Intermediate 5 ............. 5 
1.3 Synthesis of Cyclization Precursor 5 .......................................................... 6 
1.4 THF Formation and Attempted THP Formation .......................................... 7 
1.5 Cobalt-Assisted THF Formation of Epoxy-Alcohol 19 ................................ 8 
1.6 Formation of the Bicyclic Ether Moiety 22 .................................................. 8 
1.7 Completion of Vinyl Iodide 2 ....................................................................... 8 
1.8 2nd Generation Retrosynthetic Disconnection of Bicyclic Ether 2 ............... 9 
1.9 Synthesis of Dihydropyrone 25 .................................................................. 9 
1.10 Synthesis of Tetrahydropyrone 10 ........................................................... 10 
1.11 Synthesis of Bicyclic Intermediate 23 ....................................................... 11 
1.12 Completion of Bicyclic Fragment 2 ........................................................... 11 
1.13 A Model for the Construction of the Z,Z,E-Trienoate Moiety .................... 12 
1.14 Retrosynthetic Disconnection of THP Fragment 3 ................................... 12 
 
xii 
 
1.15 Synthesis and Aldol Addition of Methyl Ketone 41 and Aldehyde 40 ....... 13 
1.16 Synthesis of Cyclic Mixed Acetal 46 ......................................................... 13 
1.17 Completion of Sulfone 3 ........................................................................... 14 
1.18 Retrosynthetic Disconnection of DHP Fragment 4 ................................... 15 
1.19 Asymmetric Hetero Diels-Alder ................................................................ 15 
1.20 Synthesis of Vinyl Bromide 53 .................................................................. 15 
1.21 Completion of Aldehyde 4 ........................................................................ 16 
1.25 Four Synthetic Fragments of (+)-Sorangicin A as  
Reported by Schinzer ............................................................................... 17 
1.26 Retrosynthetic Disconnection of THP 64 and Bicyclic Ether  
65 from a Common Intermediate .............................................................. 18 
1.27 Synthesis of Diols 74 and 75 .................................................................... 18 
1.28 Synthesis of Epoxide 78 ........................................................................... 19 
1.29 Completion of THP Fragment 64 .............................................................. 20 
1.30 Completion of Bicyclic Ether Fragment 81 ............................................... 20 
1.31 Retrosynthetic Disconnection of DHP Fragment 66 ................................. 21 
1.32 Synthesis of DHP Fragment 66 ................................................................ 21 
1.33 Synthesis of Side Chain Fragment 67 ...................................................... 22 
xiii 
 
1.34 Retrosynthetic Disconnection of DHP 89 Yielding  
Two Distinct Intermediates ....................................................................... 23 
1.35 Synthesis of DHP Fragment 89 Utilizing a  
Glycolate Aldol/RCM Strategy .................................................................. 23 
1.36 Synthesis of DHP Fragment 89 Utilizing a Rhodium-Catalyzed 
 Etherification Strategy ............................................................................. 24 
2.1 Possible Retrosynthetic Disconnections of (+)-Sorangicin A and  
the Three Core Synthetic Fragments ....................................................... 33 
2.2 Retrosynthetic Disconnection of the Bicyclic Moiety and a  
Proposed Cyclization Strategy ................................................................. 35 
2.3 Synthesis of Diol 121 ............................................................................... 37 
2.4 Attempted Formation of Unsaturated Ester 124 ....................................... 38 
2.5 Synthesis of Unsaturated Ester 127 ......................................................... 38 
2.6 Completion of Tosylate 109...................................................................... 40 
2.7 Stepwise and One-Pot Formation of Bicyclic Ether Fragment 23 ............. 41 
2.8 Synthesis of p-Nitrobenzoate 131 ............................................................ 42 
2.9 Completion of Bicyclic Ether Fragments 133 and 104 .............................. 43 
2.10 Retrosynthetic Disconnection and Comparison of the THP  
and Bicyclic Ether Moieties ...................................................................... 44 
2.11 Proposed Formation of the THP Moiety ................................................... 45 
xiv 
 
2.12 Synthesis of Cross Metathesis Substrates 142 and 143 .......................... 45 
2.13 Completion of the Cyclization Precursor 147 ........................................... 46 
2.14 Cyclization and Completion of the THP .................................................... 48 
2.15 Proposed Elaboration of THP 105 ............................................................ 48 
2.16 Tandem Deprotection/Oxidation of Silyl Ether 105 ................................... 49 
2.17 Coupling Aldehyde 151 and Vinyl Iodide 152 ........................................... 50 
2.18 Completion of Acetonide 150 ................................................................... 50 
2.19 Retrosynthetic Disconnection of the DHP Moiety 156 .............................. 52 
2.20 Synthesis of RCM Precursor 158 ............................................................. 53 
2.21 RCM of Triene 158 ................................................................................... 54 
2.22 Stereochemical Rationale for the Formation of DHP 106 ......................... 55 
2.23 Coupling Fragments for the DHP Moiety and Relevant  
Coupling Strategies ............................................................................................. 58 
2.24 Synthesis of Alkyne 171 ........................................................................... 59 
2.25 Synthesis of Tetraene 172 and Attemped Synthesis of  
Vinyl Iodide 173 .................................................................................................. 59 
2.26 Synthesis of C10-epi-174........................................................................  60 
2.27 Synthesis of t-Butyl Ester 181 .................................................................. 61 
xv 
 
2.28 Completion of Vinyl Stannane 185 ........................................................... 62 
2.29 Summary of the Synthesis and Elaboration of the Three Core  
Fragments of (+)-Sorangicin A ................................................................. 63 
3.1 General Coupling Strategies for (+)-Sorangicin A .................................... 69 
3.2 Cross Metathesis between the Bicyclic Ether Moiety and the  
THP Subunit ............................................................................................. 70 
3.3 Optimized Cross Metathesis between the Bicyclic Ether 104  
and THP 105 ............................................................................................ 71 
3.4 Cross Metathesis between Bicyclic Ether 104 and THP 150.................... 72 
3.5 Path A Coupling Strategies ...................................................................... 73 
3.6 Synthesis of Aldehyde 197 ....................................................................... 73 
3.7 Coupling Alkyne 171 and Aldehyde 197 .................................................. 74 
3.8 Stereochemical Model for the Addition of Lithiated Alkyne L-171  
to Aldehyde 197 ....................................................................................... 75 
3.9 Attempted Determination of the C-21 Configuration of Alcohol 198 ......... 75 
3.10 Failed Reduction of Propargyl Alcohol 198 .............................................. 76 
3.11 1st Generation Cross Metathesis Coupling Strategy................................. 77 
3.12 Synthesis of Acetonide 203 and Attempted Cross Metathesis  
with Tetraene 172 .................................................................................... 78 
xvi 
 
3.13 2nd Generation Cross Metathesis Coupling Strategy ................................ 78 
3.14 Synthesis of Cross-Coupled Partner 206 and Cross Metathesis  
with Olefin 106 ......................................................................................... 79 
3.15 3rd Generation Cross Metathesis Coupling Strategy ................................ 80 
3.16 Synthesis of Triene 209 ........................................................................... 81 
3.17 Cross Metathesis between Free Alcohol 209 and DHP 181..................... 81 
3.18 Synthesis of Vinyl Iodide 212 ................................................................... 82 
3.19 Proposed Completion of (+)-Sorangicin A from Vinyl Iodide 212 ............. 83 
3.20 Attempted Formation of Alcohol 214 ........................................................ 84 
3.21 Proposed Coupling  via a Palladium Catalyst ........................................... 85 
3.22 Synthesis of Vinyl Iodide 219 ................................................................... 85 
3.23 Deprotection of Silyl Ether 219 and Elimination of HI from  
Vinyl Iodide 215 ........................................................................................ 86 
3.24 Coupling Vinyl Iodide 215 and Vinyl Stannane 216 .................................. 87 
3.25 Proposed Completion of (+)-Sorangicin A from Complex  
Intermediate 218 ...................................................................................... 87 
3.26 Coupling of the Bicyclic Ether Fragment 104 and Various THP  
Moieties .................................................................................................... 88 
xvii 
 
3.27 Coupling Attempts Utilizing Aldehyde 205 ............................................... 89 
3.28 Use of Cross Metathesis to Form the C-15/C-16 Double Bond  
and Further Elaboration ........................................................................... 90 
3.29 Palladium-Mediated Cross-Coupling to Afford Trienoate 218  
and Attempted RCM ................................................................................. 91 
3.30 Proposed Completion of (+)-Sorangicin A ................................................ 92 
 
 
 
 
 
 
 
 
 
 
 
 
xviii 
 
List of Abbreviations 
Ac   Acetyl 
AIBN   Azobis(isobutyronitrile) 
Bn   Benzyl 
BRSM   Based on recovered starting material 
Bu   Butyl 
CAN   Ceric ammonium nitrate 
Cp   Cyclopentadienyl 
CSA   Camphorsulfonic acid 
Cy   Cyclohexyl 
Dba   1,8-Diazabicyclo[5.4.0]undec-7-ene 
DCC   Dicyclohexyl carbodiimide 
DDQ   2,3-Dichloro-5,6-dicyano-1,4-benzoquinone 
DEAD   Diethyl azodicarboxylate 
DET   Diethyl tartrate 
DHP   Dihydropyran 
DHQ   Dihydroquinyl 
xix 
 
DIC   Diisopropyl carbodiimide 
DMAP   4-Dimethylaminopyridine 
DMP   2,2-Dimethoxypropane 
DMPU  1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
DMSO  Dimethyl sulfoxide 
Dppf   1,1’-Bis(diphenylphosphino)ferrocene 
Et   Ethyl 
F.A.B   Fast atom bombardment 
HMDS  Hexamethyldisilazide 
HMPA   Hexamethylphosphoramide 
HWE   Horner-Wadsworth-Emmons 
Icr   Isocaranyl 
Ipc   Isopinocampheol 
LDA   Lithium diisopropylamide 
Me   Methyl 
Mes   Mesityl 
MIC   Minimal inhibitory concentrations 
xx 
 
MOM   Methoxymethyl 
MS   Molecular sieves 
Ms   Methanesulfonyl 
NBS   N-Bromo succinimide 
N-H-K   Nozaka-Hiyama-Kishi 
NME   N-Methylephedrine 
NMO   N-Methylmorpholine-N-oxide 
NMP   N-Methylpyrrolidinone 
Ph   Phenyl 
Pin   Pinacol 
Piv   Pivaloyl 
PMB   p-Methoxybenzyl 
PMP   p-Methoxyphenyl 
PNB   p-Nitrobenzyl 
PPTS   Pyridinium p-toluenesulfonate 
Pr   Propyl 
Pyr.   Pyridine 
xxi 
 
RCM   Ring-closing metathesis 
Rcvd   Recovered 
SM   Starting material 
TBDPS  t-Butyldiphenylsilyl 
TBS   t-Butyldimethylsilyl 
TES   Triethylsilyl 
Tf   Trifluoromethanesulfonyl 
TFA   Trifluoroacetic acid 
THF   Tetrahydrofuran 
THP   Tetrahydropyran 
TIPS   Triisopropylsilyl 
TMS   Trimethylsilyl 
TPAP   Tetrapropylammonium perruthenate 
Trisyl   2,4,6-Triisopropylbenzenesulfonyl 
Ts   p-Toluenesulfonyl
CHAPTER ONE 
BACKGROUND INFORMATION AND REPORTED SYNTHETIC EFFORTS 
 
1.1  Isolation 
Figure 1.1. (+)-Sorangicin A. 
 
The myxobacterium Sorangium (Polyangium) cellulosum, strain So ce12, 
was initially isolated from a soil sample in 1978 from Xcaret, Mexico,1 while 
Jansen and coworkers identified its main component, (+)-sorangicin A (1) in 1985 
(Figure 1.1).2,3  Extraction from either the fermentation broth or the cell free 
culture medium followed by separation and purification, provided the natural 
product as a crystalline solid.  About 560 mg was isolated from 900 L of the 
fermentation broth.  
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1.2  Structural Elucidation 
The molecular weight, 806, and molecular formula, C47H66O11, were 
confirmed by negative ion F.A.B mass spectrometry and elemental analysis.3,4  
Extensive 1D and 2D 1H and 13C NMR were used in conjuction with X-ray 
crystallography to determined the structure of the natural product.  Complete 
structural elucidation from single crystal X-ray analysis (Figure 1.2) proved 
insufficient.  Specifically, the hybridization of the C17-C18 bond was ambiguous 
as the C17-C18 bond length (131 pm), C16-C17-C18 bond angle (116.7°), C17-
C18-C19 bond angle (120.3°), and the C16-C17-C18-C1 9 torsion angle (167.9°) 
indicated sp2 character while the C17 and C18 H atom localization indicated sp3 
hybridization.   
Figure 1.2. X-Ray Crystallographic Data for (+)-Sorangicin A as Reported by Jansen.4 
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Although the configurations of all 15 stereocenters were reported 
accurately by Jansen, ambiguous graphical representation of the C10 
stereocenter led to inaccurate representation in many peer reviewed journals, 
including publication from the Crimmins’ laboratory.5-11  It was not until 2009 that 
Smith clarified that the C10 configuration is S, as depicted in Figure 1.1, and not 
R.   
 1.3  Biogenesis 
The biogenesis of (+)-sorangicin A was studied by feeding experiments 
with both singly- and doubly- labeled 13C-acetates, sodium 13C-
hydrogencarbonate, and methyl-13C-methionine.12  It was determined that the 
natural product resulted from the linear assembly of 20 acetates onto a three-
carbon starter derived from malonate and a cleaved acetate group, with the four 
methyl groups arising from methionine. 
1.4   Biological Activity 
Prior to the isolation, identification, and biological assay of (+)-sorangicin 
A, its parent myxobacterium, Sorangium cellulosum, had been studied for its role 
in cellulose degradation in soil.13  Independent of these studies, Sorangium 
cellulosum showed activity against Gram-positive bacteria during an antibiotic 
screening program.1  These preliminary results launched a thorough investigation 
of the biological profile of (+)-sorangicin A (1).  The natural product exhibits 
minimal inhibitory concentrations (MIC) against Gram-positive bacteria (e.g., 
Staphylococcus aureas) in 3-25 µg/mL, and as low as 0.01-0.3 µg/mL against 
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Gram-negative bacteria (e.g. Escherichia coli). These features mark (+)-
sorangicin A as the most potent myxobacterial antibiotic to date and have 
encouraged extensive studies into its mode of biological activity.14  It has been 
shown that (+)-sorangicin A inhibits RNA polymerase (RNAP) similar to the 
rifamycin antibiotics, the only class of RNAP inhibitors that have been used 
clinically.15  Competition studies between rifampicin, a rifamycin antibiotic, and 
(+)-sorangicin A likewise indicate significant binding site overlap.16  Further 
testament to the importance of the biological activity of (+)-sorangicin A lies in its 
cross-resistance to rifampicin-resistant RNAP mutants.7   
In combination with its unique and complex structure, these interesting 
biological characteristics of (+)-sorangicin A have prompted several 
investigations towards the total synthesis of (+)-sorangicin A.  While no complete 
syntheses have been reported to date, synthetic studies have been published in 
peer reviewed journals by the Smith,6,8,17 Schinzer,9 and Lee laboratories,5 as 
well as our own.18 
1.5   Published Synthetic Efforts 
1.5.1 Synthetic Efforts Reported by Smith 
In efforts towards the construction of (+)-soragnicin A the Smith lab has 
published the syntheses of the three fragments shown in Scheme 1.1.6,8,17  
Although it is not explicitly stated in any publication, the functionalities present in 
these fragments suggest that specific reactions will be used in their late-stage 
coupling.   Aldehyde-containing bicyclic ether 2 and sulfone-containing THP 3 are 
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functionalized for coupling via a Julia-Kocienski olefination to form the C29-C30 
double bond.  The THP moiety 3 and the aldehyde-containing DHP fragment 4 
will likely be coupled in the same manner following minor functional group 
modification.  Finally, joining of the DHP (4) and bicyclic ether (2) fragments, will 
most likely involve a palladium-mediated coupling and an esterification.   
Scheme 1.1. Three Synthetic Fragments of (+)-Sorangicin A as Reported by Smith. 
 
1.5.1.1 1st Generation Synthesis of the Bicyclic Ether Fragment 
Smith has reported the completion of aldehyde 2 via two synthetic routes.  
The first route proposed formation of the bicyclic ether from bis-epoxide 5 via an 
acid-catalyzed cascade of epoxide openings (Scheme 1.2).8 
Scheme 1.2. Bicyclic Ether Fragment 2 and Key Retrosynthetic Intermediate 5. 
 
 The synthesis of bis-epoxide 5 began with diol 6.  Bis-protection as PMB 
ethers followed by the oxidative cleavage of the olefin yielded aldehyde 7.19  
Asymmetric Brown crotylation20 with the chiral boron 8 provided homoallylic 
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alcohol 9, which upon protection as the bis-PMB ether and Sharpless asymmetric 
dihydroxylation21 afforded diol 10.  Fraser-Reid epoxidation22 was immediately 
followed by exposure to the lithiated diyne derived from 1,4-bis(trimethylsilyl)-1,3-
butadiyne,23 and subsequent exposure to lithium aluminum hydride was able to 
stereo- and chemoselectively reduce the internal triple bond to enyne 11.24  
Oxidative cleavage of the PMB ethers followed by a second Fraser-Reid 
epoxidation afforded epoxy-alcohol 12.  Cyclization precursor 5 was then 
achieved upon exposure of enyne 12 to Shi asymmetric epoxidation 
conditions.25,26 
Scheme 1.3. Synthesis of Cyclization Precursor 5. 
 
 With bis-epoxide 5 in hand, Smith investigated the first selective epoxide-
opening/ring-closing event.  The first attempt to cyclize appeared successful 
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upon treatment with dicobalt octacarbonyl followed by boron trifluoride diethyl 
etherate, which afforded THF 13 (Scheme 1.4).27,28  However, the desired 
bicyclic compound 17 was never realized from cobalt complex 13, as various 
attempts to cyclize under acidic conditions afforded a mixture of newly-formed 
six- and seven-membered rings (14-16), none of which possessed the desired 
attributes. 
Scheme 1.4. THF Formation and Attempted THP formation 
 
 Based on X-ray crystal analysis, Smith then reasoned that the presence of 
the cobalt complex disfavored formation of the desired six-membered bicyclic 
compound 17.  Cyclization was subsequently attempted on the THF after 
oxidative removal of cobalt from the previously accessed intermediate 19 
(Scheme 1.5). 
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Scheme 1.5. Cobalt-Assisted THF Formation of Epoxy-Alcohol 19. 
 
 Although treatment of THF 19 with various acidic conditions promoted 
formation of the desired six-membered ring 20, it was unselective over the 
seven-membered ring 21.  Only after the TMS group had been removed was the 
desired bicyclic ether moiety formed as the major product. Following deprotection 
of the alkyne, optimized conditions afforded the desired bicyclic alcohol 22 
selectively over the undesired bicycle 23 (2.1:1 dr) in an isolated yield of 65% 
(Scheme 1.6). 
Scheme 1.6. Formation of the Bicyclic Ether Moiety 22. 
 
 Hydrostannylation29,30 and iodination followed by oxidation31 of the alcohol 
proceeded uneventfully to provide the desired aldehyde 2 (Scheme 1.7). 
Scheme 1.7. Completion of Vinyl Iodide 2. 
O
OMe
OH
1) i. Bu3SnH, AIBN
ii. I2, CH2Cl2
2) Dess-Martin [O]
77%, 2 steps
O
OMe
O
I22 2
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1.5.1.2 2nd Generation Synthesis of the Bicyclic Ether Fragment 
According to Smith, the previously discussed route to aldehyde 2 was not 
amenable to material advancement, and a 2nd generation synthesis was 
subsequently reported.  This revised route involved interception of the same 
bicyclic intermediate 23, reported by our lab.  The bicyclic alcohol 23 was 
assembled through an epoxide-opening/ring-closing sequence performed on 
tetrahydropyrone 24, accessed via a Michael addition/enolate trapping sequence, 
performed on dihydropyrone 25 (Scheme 1.8). 
Scheme 1.8. 2nd Generation Retrosynthetic Disconnection of Bicyclic Ether 2. 
 
 Synthesis of dihydropyrone 25 was effected via an asymmetric Diels-Alder 
reaction between commercially available aldehyde 26 and the Danishefsky diene 
(27) utilizing the chromium(III)-Schiff base catalyst 28,32 followed by acidic 
hydrolysis of the resultant silyl enol ether (Scheme 1.9). 
Scheme 1.9. Synthesis of Dihydropyrone 25. 
H
O
O
Me
Me
O
MeO OTMS
i. catalyst 28,
BaO, EtOAc
ii. TFA, CH2Cl2
(86%, 33:1 dr)
+
O
O
O
O
Me
Me
H
N O
O
Cr
Cl
Me
28
26 27 25
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 Next, a three component coupling between dihydropyrone 25, a Michael 
donor, and an electrophile was attempted.33  Treatment of enone 25 with the 
mixed zincate derived from E-bromostyrene (29) furnished intermediate zinc 
enolate 30.  Initial attempts at the enolate trapping with methyl iodide required 
forcing conditions (~10 eq. of both HMPA and MeI) and resulted in only 51% of 
the desired tetrahydropyrone plus 20% of the bis-alkylated substrate 31.  
Addition of Cu•PBu3 proved effective at suppressing double alkylation yielding 
the desired product 24 in 73%. 
Scheme 1.10. Synthesis of Tetrahydropyrone 24. 
 
 Further elaboration of tetrahydropyrone to bicyclic intermediate 23 was 
then achieved over four steps (Scheme 1.11).  Stereoselective reduction of 
ketone 24 yielded alcohol 32.  Deprotection under acidic conditions provided triol 
33, which was exposed to 2,4,6-triisopropylbenzenesulfonyl chloride (TrisylCl) 
affording primary sulfonate 34.  Treatment with potassium hexamethyldisilazide 
(KHMDS) effected both epoxide formation and subsequent epoxide opening to 
form the five-membered ring34 in bicyclic ether 23, previously reported by our 
lab.18   
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Scheme 1.11. Synthesis of Bicyclic Intermediate 23. 
 
 The remainder of the desired coupling fragment 2 was then assembled in 
four steps from alcohol 23 (Scheme 1.12).  Parikh-Doering oxidation35 followed 
by subjection of crude aldehyde 35 to Takai olefination conditions36 yielded vinyl 
iodide 36 in 68% as a diastereomeric mixture (3.2:1 E:Z).  Finally, selective 
dihydroxylation37 of the styrene olefin was followed by oxidative cleavage to 
provide aldehyde 2. 
Scheme 1.12. Completion of Bicyclic Fragment 2. 
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 Additionally, Smith was able to successfully append the trieneoate moiety 
of the natural product (Scheme 1.13).  Vinyl iodide 2 was cross-coupled38 with 
known vinyl stannane 37.39  Hydrolysis of the newly formed trieneoate 38 yielded 
the corresponding acid 39 amenable for lactonization or esterification. 
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Scheme 1.13. A Model for the Construction of the Z,Z,E-trieneoate Moiety. 
 
1.5.1.3 Synthesis of the THP Fragment 
Smith’s approach for constructing the THP fragment 3 relied on an 
aldol/dehydration sequence between aldehyde 40 and methyl ketone 41 
(Scheme 1.14). 
Scheme 1.14. Retrosynthetic Disconnection of THP Fragment 3. 
 
Synthetic efforts began with the synthesis of methyl ketone 41 and 
aldehyde 40 (Scheme 1.15).  Reduction of known lactone40 upon exposure to 
diisobutylaluminum hydride provided the lactol which was treated with 
trimethylsilyldiazomethane to afford alcohol 43.41  The necessary methyl ketone 
41 was then formed after an oxidation/methyl addition/oxidation sequence.  
Aldehyde 40 was accessed in three steps from known aldol adduct 44.6  
Protection of the alcohol as the TES ether, reductive removal of the chiral 
auxiliary, and oxidation proved successful in providing aldehyde 40.  The ensuing 
boron-mediated aldol addition provided the corresponding alcohol product as a 
mixture of diastereomers.42  
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Scheme 1.15. Synthesis and Aldol Addition of Methyl Ketone 41 and Aldehyde 40. 
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 The separable mixture of diastereomers was then advanced after 
treatment with acidic methanol to yield cyclic mixed acetals 46 and 47 in good 
yield (Scheme 1.16).  At this juncture the modest diastereoselectivity of the aldol 
addition could be rectified as the undesired diastereomer 47 could be converted 
to the desired configuration via a simple oxidation/reduction sequence.43  
Scheme 1.16. Synthesis of Cyclic Mixed Acetal 46. 
 
 The completion of THP fragment 3 was then achieved over several 
transformations as shown in Scheme 1.17.  Dehydration of the mixed acetal 46 
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followed by protection of the secondary alcohol afforded DHP fragment 48.  Next, 
conversion of the terminal alkyne to trans olefin 50 was effected by formation of 
the vinyl iodide,44 and subsequent Suzuki-Miyaura cross-coupling45 with boronate 
49.  The benzyl ethers were reductively cleaved under dissolving metal 
conditions and the resultant diol was reprotected as the acetonide.  Selective 
removal of the t-butyldiphenylsilyl (TBDPS) group was carried out under basic 
conditions to afford primary alcohol 51,46 which was subjected to Mitsunobu 
conditions47 with 1-phenyl-1H-tetrazole-5-thiol, and ultimately oxidized to give the 
desired sulfone 3. 
Scheme 1.17. Completion of Sulfone 3. 
 
1.5.1.4 Synthesis of the DHP Fragment 
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Scheme 1.18. Retrosynthetic Disconnection of DHP Fragment 4. 
 
 DHP fragment 4 was envisioned to arise via Michael addition of the vinyl 
cuprate derived from vinyl bromide 53 to dihydropyrone 52 (Scheme 1.18).  In a 
similar fashion to Smith’s 2nd generation synthesis of bicyclic ether 2 (Scheme 
1.8), known enone 52 was accessed via an asymmetric hetero-Diels-Alder 
between aldehyde 54 and Danishefksy’s diene 2748 catalyzed by chromium(III)-
catalyst 28 (Scheme 1.19).49,50 
Scheme 1.19. Asymmetric Hetero Diels-Alder. 
 
Scheme 1.20. Synthesis of Vinyl Bromide 53. 
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 Preparation of vinyl bromide 53 began with alkylation of the acylated 
Myers auxiliary 55 with alkyl iodide 56 (Scheme 1.20).51  Reductive removal of 
the chiral auxiliary provided aldehyde 58 which was subjected to a Corey-Fuchs 
homologation.52  A hydrozirconation/bromination sequence employing the 
Schwartz reagent and N-bromosuccinamide afforded vinyl bromide 53.44 
Scheme 1.21. Completion of Aldehyde 4. 
 
 The enolate intermediate of the Michael addition of the corresponding 
higher order cuprate to enone 52 was trapped as its triethylsilyl (TES) enol ether 
59 (Scheme 1.21).  Subjection to the Rubottom protocol53 provided the α-TES 
ether which was converted to the t-butyldimethylsilyl (TBS) ether 60.  Formation 
of the vinyl triflate with Comins reagent54 followed by a palladium-catalyzed 
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reduction55 afforded DHP 61 with the desired unsaturation and substitution.  The 
PMB ether 61 was converted to the corresponding carboxylic acid in three steps.  
The crude acid was then treated with isourea 62 to provide the t-butyl ester 63.56  
Finally, selective deprotection of the TBS ether with buffered fluoride followed by 
oxidation with Dess-Martin periodinane yielded aldehyde 4.31  Current efforts are 
underway to fuse these segments together and form the backbone of the natural 
product. 
1.5.2 Synthetic Efforts Reported by Schinzer 
Similar to Smith’s retrosynthetic disconnections, Schinzer envisioned 
simplifying (+)-sorangicin A into three main synthetic fragments (64-66) and the 
C8 alkyl side chain moiety 67 (Scheme 1.25).  Two of the fragments, bicyclic 
ether 65 and THP 64, were accessed from one common intermediate.  While the 
synthetic handles of each fragment that are contained in the macrocycle were 
orthogonally protected, Schinzer failed to provide any insight into his ultimate 
coupling strategy for the completion of the (+)-sorangicin A. 
Scheme 1.25. Four Synthetic Fragments of (+)-Sorangicin A as Reported by Schinzer. 
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1.5.2.1 Synthesis of the Bicyclic Ether and THP Fragments From One 
Synthetic Intermediate 
Scheme 1.26. Retrosynthetic Disconnetion of THP 64 and Bicyclic Ether 65 from a 
Common Synthetic Intermediate. 
 
 Both heterocyclic compounds were formed via an epoxide-opening/ring-
closing strategy.  Additionally, both the THP unit 64 and the bicyclic ether 65 
were accessed via a non-selective dihydroxylation of a common intermediate, 
terminal olefin 68 (Scheme 1.26).   
Scheme 1.27.  Synthesis of Diols 74 and 75. 
 
 This key terminal olefin 68 was accessed in four steps from 1,3-
propanediol (69) (Scheme 1.27). Monoprotection with TBSCl followed by Swern 
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oxidation57 of the resultant primary alcohol afforded aldehyde 70 (Scheme 1.27).  
An asymmetric Brown crotylation20 followed by protection of the homoallylic 
alcohol as the TIPS ether provided terminal olefin 72. 
 Exposure of terminal olefin 72 to non-selective dihydroxylation conditions58 
afforded two diastereomeric diols 74 and 75.  Diol 74 with the syn,syn 
relationship was carried on to the THP fragment 64, while diol 75 with the 
anti,syn relationship was advanced to the bicyclic ether fragment 65 (Scheme 
1.26). 
 Construction of the THP fragment continued with concomitant acidic 
protection of the diol and cleavage of the TBS ether (Scheme 1.28).  
Oxidation59,60 of the primary alcohol afforded aldehyde 76 which underwent a Z-
selective Horner-Wadsworth-Emmons olefination61 and 1,2-reduction to give 
allylic alcohol 77.  Epoxidation62 of the internal olefin followed by protection of the 
free alcohol provided epoxide 78.  
Scheme 1.28. Synthesis of Epoxide 78. 
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 Completion of the THP fragment 64 was easily achieved upon acidic 
deprotection of acetonide 78 with CSA, which further promoted the favorable 6-
exo cyclization over several larger possible rings (Scheme 1.29).   
Scheme 1.29. Completion of THP Fragment 64. 
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 To synthesize bicyclic ether fragment 65, the anti,syn diastereomer of the 
non-selective dihydroxylation (75, Scheme 1.27) was subjected to the same 
seven-step sequence as detailed in Schemes 1.28 and 1.29.  Diol 79 underwent 
a number of protecting group manipulations prior to ultimate sulfonylation to 
afford mesylate 80 in 59% yield, and fortuitously 28% yield of the desired bicyclic 
fragment 81 (Scheme 1.30).  Mesylate 82 was then exposed to DDQ to 
selectively cleave the PMB ether and the resultant alcohol, upon exposure to 
base, closed the five-membered ring to yield the bicyclic ether fragment 81. 
Scheme 1.30. Completion of Bicyclic Ether Fragment 81. 
 
21 
 
1.5.2.2 Synthesis of the DHP and Side Chain Fragments 
Scheme 1.31. Retrosynthetic Disconnection of DHP Fragment 66. 
 
 The DHP fragment (66) Schinzer pursued was accessed from diol 83 
(Scheme 1.31).  The allyl group was installed via an L-glucal allylation, the L-
glucal was derived from L-glucose (84). 
Scheme 1.32. Synthesis of DHP Fragment 66. 
 
 The synthesis of the DHP subunit began with the known conversion of L-
glucose to tri-O-acetyl-L-glucal (84),63 which was deprotected via exposure to 
basic methanol to afford L-glucal 85 (Scheme 1.32).  Subjection to TMSOTf 
followed by addition of allylsilane yielded the DHP 83.64  Both remaining alcohols 
were protected as TBS ethers, and the terminal olefin was chemoselectively 
cleaved to the aldehyde utilizing Sharpless conditions.37  Conversion of the 
aldehyde to the corresponding dimethyl acetal was effected with trimethyl 
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orthoformate65 and the primary TBS ether was selectively cleaved with CSA to 
yield alcohol 86.  The methyl ketone was then installed by a three-step sequence 
involving oxidation57 of the primary alcohol to the aldehyde, methyl Grignard 
addition, and subsequent oxidation31 thus completing the desired DHP fragment 
66. 
 Synthesis of the side chain fragment began with acylation of the Seebach 
auxiliary (87)66 with 6-heptenoyl chloride (88) (Scheme 1.33).  Subsequent 
alkylation with methyl iodide proceeded with excellent diastereomeric excess 
(de), and reductive removal of the auxiliary with lithium aluminum hydride 
afforded the desired side chain fragment 67, previously synthesized in the 
Schinzer laboratory.67  Further efforts are currently underway to join these 
fragments and complete the synthesis of the natural product. 
Scheme 1.33. Synthesis of Side Chain Fragment 67. 
 
1.5.3 Synthetic Efforts Reported by Lee 
The Lee lab has detailed two different synthetic routes to DHP core 89, 
both utilizing a ring-closing metathesis (RCM) reaction to form the six-membered 
ring (Scheme 1.36).  Synthesis of the DHP moiety via acyloxazolidinone 90 relied 
on glycolate aldol/RCM methodology developed by our lab68,69 to prepare the 
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RCM precursor, while synthesis from diene 91 hinged on a rhodium-catalyzed 
allylic etherification. 
Scheme 1.34. Retrosynthetic Disconnetion of DHP 89 Yielding Two Distinct Intermediates. 
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Scheme 1.35. Synthesis of DHP Fragment 89 Utilizing a Glycolate Aldol/RCM Strategy. 
 
 Synthesis of DHP intermediate 89 began with known chiral alcohol 92 
(Scheme 1.37).70  Alkylation with the sodium salt of bromoacetic acid afforded 
glycolic acid 93.  Conversion to the mixed pivalic anhydride and exposure to the 
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lithiated oxazolidinone 94 provided N-glycolyloxazolidinone 95.  Next, treatment 
of the acylated oxazolidinone 95 to syn-aldol conditions yielded diene 90.68,69  
Transformation of the aldol-adduct to the RCM precursor was effected by 
protection of the alcohol and reductive removal of the auxiliary to afford diene 96.  
Subsequent exposure to Grubbs 1st generation catalyst (97) completed the 
desired DHP core 89.71 
Scheme 1.36. Synthesis of DHP Fragment 89 Utilizing a Rhodium-Catalyzed 
Etherification/RCM Strategy. 
 
 The alternate synthetic strategy investigated by Lee began with an 
Evans syn-aldol reaction of chiral oxazolidinone 98 with acrolein (Scheme 
1.38).72  Protection of the newly formed alcohol 99 followed by reductive removal 
of the auxiliary yielded primary alcohol 100.  Further protecting group 
manipulation afforded alcohol 101 which was subjected to the rhodium-catalyzed 
etherification with carbonate 102 utilizing conditions developed by Evans to 
afford allylic ether 91.73  Finally, selective cleavage of the primary TBS ether 
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afforded diene 103, which underwent RCM to deliver DHP 89 (1.37).  Ongoing 
efforts toward the completion of sorangicin are currently in progress. 
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CHAPTER TWO 
SYNTHESIS OF THE CORE SYNTHETIC FRAGMENTS 
 
2.1 Synthetic Strategy 
Scheme 2.1. Possible Retrosynthetic Disconnections of (+)-Sorangicin A and the Three 
Core Synthetic Fragments. 
 
Like the previously reported approaches toward (+)-sorangicin A,1-4 we 
sought to simplify the natural product into three core fragments: a bicyclic ether 
fragment, a tetrasubsituted tetrahydropyran (THP) fragment, and a trisubstituted 
dihydropyran (DHP) fragment.  However, instead of devising one retrosynthetic 
scheme with distinct disconnections, we intended to develop a modular approach 
allowing for the investigation of several late-stage coupling strategies of these 
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three easily modified fragments.  It was envisioned that the fragments 
shown in Scheme 2.1 would meet this criteria.  Each fragment’s termini contains 
a selectively modifiable, protected alcohol and a terminal olefin, enabling the 
exploration of numerous coupling and macrocyclization techniques. 
Late-stage installation of the trienoate moiety was envisioned as it is 
known to be sensitive to various reaction conditions.5  Formation of the triene 
would be possible through a palladium-catalyzed coupling reaction, specifically 
employing either Stille or Suzuki-Miyaura reaction conditions6 to form the C38-
C39 bond, the C40-C41 bond, or both in a double cross-coupling event.  Further, 
this coupling could serve to form the macrocycle.  If this approach proved 
problematic a second option would involve lactonization7 at C43 after the triene 
moiety was assembled.   
Additionally, late-stage macrocyclization or cross-coupling could be 
effected via cross metathesis to form the olefins at either C15-C16 or C19-C20.  
Another option for coupling the THP and the DHP subunits is C20-C21 bond 
formation.  Several amenable methods exist for the formation of allylic alcohols 
including acetylide addition/reduction,8,9 vinyl zinc addition,10 and the Nozaki-
Hiyama-Kishi reaction.11  Finally, we envisioned the initial coupling joining the 
bicyclic ether moiety and the THP fragment to form the C29-C30 olefin.  Either a 
cross metathesis12 or an E-selective Julia-Kocienski olefination13 could be 
utilized. 
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2.2 Synthesis of the Bicyclic Ether Fragment 
2.2.1 Synthetic Strategy 
Scheme 2.2. Retrosynthetic Disconnection of the Bicyclic Moiety and a Proposed 
Cyclization Strategy. 
 
Retrosynthetic disconnection of the bicyclic ether subunit 107 of (+)-
sorangicin A (1), via two SN2 reactions, yields diene 108 (Scheme 2.2).  We 
predicted that tosylate 109 would serve as an appropriate proxy and allow for 
assembly of bicyclic ether 23 following an epoxide-opening, an epoxide-
formation, and a second epoxide-opening.  Upon initial treatment of tosylate 109 
with acid hydrolysis of the p-methoxybenzyl acetal would unmask the diol 110 
and promote the first ring closure via a 6-exo epoxide opening.14   
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Figure 2.1. Conformations for 6-exo and 5-endo Epoxide Openings of Diol 110. 
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Although a 5-endo pathway is possible, orbital alignment supports the 
proposal that 6-membered ring formation (111) would be favored.15,16  As shown 
in Figure 2.1, a 6-membered conformation orients all substituents at pseudo-
equatorial positions and allows for favorable orbital overlap between the oxygen 
lone pair and the epoxide C-O antibonding orbital.  The 5-membered 
conformation possesses very poor orbital overlap between the HOMO and 
LUMO, further supporting 6-membered ring formation.   
Following the first cyclization, treatment with base would form a second 
epoxide, 112 (Scheme 2.2).17  Exposure to acid again should promote a 5-exo 
cyclization, opening the epoxide selectively over the 6-endo pathway to provide 
the bicyclic core 23 of (+)-sorangicin A.  The second epoxide opening/ring-
closing, would again be selective as molecular orbital overlap favors the desired 
cyclization. 
2.2.2 Synthesis of the Cyclization Precursor 
The synthesis of tosylate 109 began with a known anti-aldol reaction 
between propionate 113 and cinnamaldehyde (114) to yield aldol adduct 115 
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(Scheme 2.3).18  The alcohol was then protected as TES ether 116.  
Alternatively, the acidic workup of the aldol conditions developed by Evans could 
be omitted to provide the more labile TMS ether 117.  Reductive removal of the 
chiral auxiliary in silyl ethers 116 and 117 yielded aldehydes 118 and 120, 
respectively,19 which were asymmetrically allylated under conditions developed 
by Brown.20  The reduction/allylation sequence of TES ether 116 yielded 
homoallylic alcohol 119 in 85% over 2 steps.  Subsequent cleavage of the TES 
ether via exposure to tetrabutylammonium fluoride yielded diol 121.  The same 
reduction/allylation sequence performed on TMS ether 117 afforded diol 121 in 
68% over two steps.  Although the yield for diol 121 in the second was lower, it 
eliminated two steps from the linear sequence.   
Scheme 2.3. Synthesis of Diol 121. 
 
It was then necessary to elongate the carbon skeleton and incorporate a 
synthetic handle that allowed for installation of the stereocenters at C35 and C36.  
Initially, we proceeded with TES ether 119 (Scheme 2.4).  The free alcohol was 
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protected as TIPS ether 122.  A three-step dihydroxylation/oxidative 
cleavage/Horner-Wadsworth-Emmons sequence was proposed to access enoate 
124 via diol 123.  However, the dihydroxylation21 provided mainly over-oxidized 
products. 
Scheme 2.4. Attempted Formation of Unsaturated Ester 124. 
 
Scheme 2.5. Synthesis of Unsaturated Ester 127. 
 
Our efforts were consequently focused on a cross metathesis strategy to 
access unsaturated ester 127 (Scheme 2.5).  Diol 121 was protected as the p-
methoxyphenyl acetal 125.  This cyclic protecting group was chosen for two 
reasons: 1) the lowest energy conformation of the 6-membered ring was 
predicted to orient both olefinic substituents in equatorial positions, thus 
minimizing the possibility of a competing ring-closing metathesis, and 2) the 
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acidic conditions necessary to hydrolize the acetal would also open the epoxide 
in the 6-exo ring formation.  Cross metathesis conditions were subsequently 
explored between terminal olefin 125 and ethyl acrylate 126. 
The optimization of the cross metathesis between olefin 125 and ethyl 
acrylate is summarized in Table 2.1.  Our initial attempt (Entry 1), employing 5 
mol% of Grubbs’ 2nd generation catalyst 12812 at room temperature for 18 h with 
two equivalents of ethyl acrylate, afforded the desired product in 61% yield.  
Further experimentation, involving increasing the temperature (Entry 2) or 
employing Grubbs’ 1st generation catalyst 97 (Entry 3)12 or the dimer of olefin 125 
(Entry 4) failed to improve the yield.  Only when the amount of ethyl acrylate was 
increased was the yield improved.  The use of 10 equivalents of ethyl acrylate led 
to a 71% yield (Entry 5) and 20 equivalents resulted in a 95% yield (Entry 6). 
Table 2.1. Cross Metathesis Conditions for Olefin 125 with Ethyl Acrylate. 
 
Entry Compound Catalyst 
(mol %) 
Temperature Time Olefin 
Equivalents 
Yield of 
127 
1 125 128 (5) rt 18 h 2 61% 
2 125 128 (5) 40 °C 3 h 2 37% 
3 125 97 (10) 40 °C 4 h 5 20% 
4 Dimer of 125 128 (5) 40 °C 18 h 4 0% 
5 125 128 (5) rt 18 h 10 71% 
6 125 128 (5) rt 18 h 20 95% 
 
Enoate 127 was subsequently reduced to the corresponding allylic alcohol 
129 (Scheme 2.6).  Subjection to asymmetric epoxidation conditions developed 
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by Sharpless afforded epoxy alcohol 130.22  It should be noted that the standard 
acidic workup conditions provided poor yields of epoxide 130, most likely due to 
the acid sensitivity of the PMP-acetal protecting group.  Development of a non-
acidic workup protocol lead to successful isolation of the desired epoxide in 
acceptable yields.  Tosylate 109 was accessed via exposure of the epoxy alcohol 
130 to p-toluenesulfonyl chloride under basic conditions. 
Scheme 2.6. Completion of Tosylate 109. 
 
2.2.3 Bicycle Formation 
Fortuitously, our first attempt to cyclize epoxy tosylate 109 with 5% HCl in 
THF and MeOH provided tetrahydrofuran 111 in 75% yield (Scheme 2.7, Path 
A).14  Further subjection to basic MeOH afforded epoxide 112;17 however, 
exposure to silica gel during purification caused degradation.  Therefore, without 
purification, crude epoxide 112 was subjected to the initial acidic conditions to 
yield the desired bicyclic ether 23 in 84% over two steps.  It is possible that the 
degradation of epoxide 112 was actually cyclization of the second ring promoted 
by the mild acidity of the silica gel.  This phenomenon, however, was not 
investigated, as it was realized that all three transformations could be carried out 
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sequentially in the same reaction vessel with identical yield to the stepwise 
procedure (Path B). 
Scheme 2.7. Stepwise and One-Pot Formation of Bicyclic Ether Fragment 23. 
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Upon scale-up of the bicyclic fragment, yields were inconsistent and 
significantly lower.  Thorough investigations indicated that the THF:MeOH ratio 
was imperative to the success of the reaction.  If the THF:MeOH ratio was 
greater than 2:1, an intermediate that retained the PMP functionality was 
observed as a major byproduct.  Conversely, if the reaction was run in MeOH 
alone, the solvent competitively opened the epoxide to give a significant 
byproduct.  A ratio of 1:10 THF:MeOH gave consistent yields at small and large 
(>1 g) scales. 
2.2.4 Structure Determination and Completion 
The p-nitrobenzoate (PNB) 131 was prepared from alcohol 23 via 
exposure to 4-nitrobenzoyl chloride and base (Scheme 2.8).  Stereochemistry 
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and absolute configuration were confirmed from the X-ray of PNB ester 131 
(Figure 2.2). 
Scheme 2.8. Synthesis of p-Nitrobenzoate 131. 
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Figure 2.2. X-Ray Crystallographic Data for p-Nitrobenzoate 131. 
 
The completion of bicyclic fragment 104 was then achieved via a three 
step sequence (Scheme 2.9).  After alcohol 23 was protected as the pivalate 
ester 132, the olefin was oxidatively cleaved to aldehyde 133 upon exposure to 
ozone.23  Finally, a Wittig methylenation afforded the desired coupling fragment 
104.24  Aldehyde 133 proved to be particularly unstable to purification or storage 
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for more than a few hours.  To obtain the highest yields, solvent was removed 
from crude aldehyde 133, which was subjected immediately to Wittig olefination 
conditions. 
Scheme 2.9. Completion of Bicyclic Ether Fragments 133 and 104. 
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Attempts to conduct the oxidative cleavage/methylenation sequence on 
the alcohol 23 in the absence of a protecting group suffered from low yields.  
Other protecting groups such as acetate and PMB ether were tolerated, although 
yields were lower with the PMB ether, likely due to sensitivity to oxidative 
conditions.  With 11- and 12-step sequences in hand to access aldehyde 133 
and olefin 104, necessary for either a Julia-Kocienski olefination13 or a 
metathesis coupling,12 our focus turned towards the tetrahydropyran subunit. 
2.3 Synthesis of the THP Fragment 
2.3.1 Similarity of the THP and Bicyclic Ether Fragments 
Inspection of the bicyclic ether and THP moieties of (+)-sorangicin A 
revealed a structural similarity between the two (Scheme 2.10).  Retrosynthetic 
disconnection of the C36-O bond in the THF ring of the bicyclic moiety 107 
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affords THP 134, which differs at only two stereocenters in the cyclic ether of 
THP subunit 135 conatined in the natural product.  Further retrosynthetic 
disconnection of the C23-O and C35-O bonds of both THP fragments 134 and 
135 respectively provides acyclic polyols 136 and 137 that still differ at only two 
stereocenters.  This structural likeness led us to devise a strategy for the 
construction of the THP moiety that parallels the synthesis of bicyclic ether 
fragment 104 (Scheme 2.9).   
Scheme 2.10. Retrosynthetic Disconnection and Comparison of the THP and Bicyclic Ether 
Moieties. 
 
2.3.2 Synthetic Strategy 
Epoxy alcohol 138 was proposed to be a suitable surrogate for subunit 
137 (Scheme 2.11).  We envisioned an acid-promoted epoxide opening to 
access the tetrahydropyran 139.14  Similar to the bicyclic fragment, two 
cyclizations are possible. However, it is proposed that the 6-exo product would 
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likewise be favored kinetically over the 7-endo adduct according to a similar 
molecular orbital overlap argument (Scheme 2.2). 
Scheme 2.11. Proposed Formation of the Tetrahydropyran Moiety. 
 
2.3.3 Synthesis of the Cyclization Precursor 
Synthesis of epoxy alcohol 138 began with a syn-aldol reaction developed 
in the Crimmins laboratory between propionate 140 and 3-butenal (141) (Scheme 
2.12).25  As learned through synthesis of the bicyclic ether moiety, metathesis 
was envisioned as the most promising means to elongate the carbon backbone.  
To this end, both homoallylic alcohol 142 and its TBS ether 143 were 
investigated as potential metathesis cross-coupling partners. 
Scheme 2.12. Synthesis of Cross Metathesis Substrates 142 and 143. 
 
Our initial experiments involved unprotected aldol adduct 142, although, it 
was quickly realized that this substrate was inactive under standard metathesis 
conditions with varying alkene coupling partners (Entries 1-4).  We then 
investigated the cross metathesis reaction of silyl-protected aldol adduct 143 with 
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ethyl acrylate as this reaction had proven fruitful in our synthesis of the bicyclic 
fragment (Entry 5).   
Table 2.2. Cross Metathesis Conditions for Aldol Adducts 142 and 143. 
 
Entry R Olefin Catalyst Result 
1 H (142) 
 
97 No rxn 
2 H (142) 
 
128 No rxn 
3 H (142) 
 
97 No rxn 
4 H (142) 
 
128 No rxn 
5 TBS (143) 
 
128 R’ = CO2Et (144) 
 
Scheme 2.13. Completion of the Cyclization Precursor 147. 
 
The cross metathesis between silyl ether 143 and ethyl acrylate was 
effected in 88% yield using Grubbs’ 2nd generation catalyst, 128 (Scheme 2.13).  
We decided not to further investigate a metathesis reaction between the 
protected aldol adduct 143 and a coupling partner with the correct oxidation state 
such as allylic alcohol because 1) metathesis with ethyl acrylate has 
demonstrated high E-selectivity,26 and 2) it was proposed that the impending 
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reductive removal of the auxiliary could also serve to reduce the ester to the 
alcohol. 
To our delight, exposure of unsaturated ester 144 to approximately six 
equivalents of diisobutylaluminum hydride reduced the ester functionality to the 
alcohol while also cleaving the amide bond, affording aldehyde 145 in good yield.  
After protection of the allylic alcohol as the acetate, aldehyde 146 was subjected 
to Brown’s asymmetric allylation conditions.20  Following standard oxidative 
workup, the crude product was subjected to a second basic methanol workup to 
cleave the ester protecting group and provide diol 147. 
2.3.4 THP Formation 
As depicted in Scheme 2.11, cyclization to the desired THP 139 should be 
promoted by exposure of epoxide 138 to acidic conditions.  When it was realized 
that the acidic workup of the Sharpless asymmetric epoxidation22 was harsh 
enough to cause unwanted side reactions in the epoxidation of allylic alcohol 133 
(Scheme 2.6), it was postulated that those acidic workup conditions would also 
promote the desired epoxide opening/ring-closing event in the current synthesis 
(Scheme 2.14).  Indeed, after epoxidation to epoxy alcohol 138 appeared 
complete by thin layer chromatography, exposure to the acidic workup conditions 
caused a slight change in retention factor and NMR confirmed the product as 
THP 139.  Bis-protection with TESCl and base provided the core tetrahydropyran 
fragment 105.  The differentially silylated THP 149 could also prepared from diol 
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139 in good yield via selective TES protection of the primary alcohol followed by 
TBS protection of the secondary alcohol in good yield. 
Scheme 2.14. Cyclization and Completion of the THP. 
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2.3.5 Elaboration of the THP  
Scheme 2.15. Proposed Elaboration of THP 105. 
 
To accommodate various proposed coupling and macrocyclization 
strategies, tetrahydropyran fragment 105 required elaboration to acetonide 150.  
Thus, with both tetrahydropyrans in hand, all of the noted coupling strategies in 
Scheme 2.1 would be easily accessible for investigation.  The acetonide 
protecting group was chosen based on reports by Jansen that detail protection of 
the C21-C22-diol of (+)-sorangicin A as the acetonide and its subsequent 
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deprotection.5  These studies also investigate several other 
protection/deprotection sequences involving the three hydroxyl groups as well as 
the carboxylic acid.  Accordingly, our late-stage deprotection strategy will be 
based on these studies and will be discussed at a later point. 
Towards the completion of acetonide 150, bistriethylsilylether 105 was 
subjected to modified Swern oxidation conditions which are known to oxidize 
primary TMS and TES ethers to aldehydes even in the presence of secondary 
silyl ethers.27  Slight modification of the reported procedure led to the formation of 
aldehyde 151 in one pot and good yield (Scheme 2.16). 
Scheme 2.16. Tandem Deprotection/Oxidation of Silyl Ether 105. 
 
We next investigated the coupling of aldehyde 151 with vinyl iodide 152, 
prepared via Takai olefination28 of the known aldehyde 153.29  According to the 
Felkin-Anh model,30 the transmetalated species should approach the aldehyde 
from the bottom face, as shown in Scheme 2.17, providing the desired 
configuration at C21.  Initial attempts to couple aldehyde 151 with the vinyllithium 
species, generated in situ from vinyl iodide 152, failed to promote the desired 
reaction.31  The alternative vinylzinc species, also documented for use in 
complex systems, provided promising results.10  Initial efforts employing diethyl 
ether as the solvent gave the coupled product 154 in 70% yield in a 2:1 
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diastereomeric ratio.  A solvent switch to THF provided a similar yield, but with a 
synthetically useful 8:1 ratio of diastereomers. 
Scheme 2.17. Coupling Aldehyde 151 and Vinyl Iodide 152. 
 
Cleavage of the TES ether with mild acid in methanol followed by 
subsequent protection of the crude diol as the acetonide afforded the desired 
coupling partner 150 in excellent yield over two steps (Scheme 2.18). 
Scheme 2.18. Completion of Acetonide 150. 
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2.3.6 Structure Determination 
The configuration of the newly formed secondary alcohol stereocenter was 
determined by 2D NMR analysis.  The minor diastereomer of the vinylzinc 
addition was carried through the same two step sequence outlined in Scheme 
2.18, and comparison of the nOe analyses of the two acetonides 150 and 155 
confirmed the correct configuration of the major product (Figure 2.3).   
Figure 2.3. Stereochemical Configuration Confirmation of THP 150 via nOe Analysis. 
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The first notable difference is the strong nOe between the two protons of 
acetonide 150 at C21 and C22 suggesting a syn relationship, while only a weak 
nOe existed between the corresponding protons on minor diastereomer 155, 
neither confirming nor contesting the suspected anti relationship.  A second, and 
more convincing detail, was the nOe detected between the acetonide methyl 
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groups and the C21 and C22 protons of both compounds.  The major 
diastereomer displayed strong nOe interactions between both protons and only 
one methyl group, again suggesting a syn relationship.  The minor diastereomer 
exhibited a strong nOe between the C21 proton and one methyl group, while the 
C22 proton displayed a strong nOe with the other methyl group of the acetonide.  
This evidence strongly suggests the minor diastereomer possesses an anti 
relationship between the C21 and C22 stereocenters. 
2.4 Synthesis of the DHP Fragment 
2.4.1 Synthetic Strategy 
Scheme 2.19. Retrosynthetic Disconnection of the DHP Moiety 156. 
 
Due to the unsaturation in the dihydropyran moiety, construction of the 
ring varied significantly from the other two core fragments of (+)-sorangicin A.  
The dihydropyran moiety (156) was envisioned to arise from PMB ether 106 
(Scheme 2.20).  The allyl substituent would be installed via nucleophilic attack on 
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an oxocarbenium formed from mixed acetal 157.32  The dihydropyran ring would 
be formed via ring-closing metathesis of triene 158.33 
2.4.2 Synthesis of the RCM Precursor 
Scheme 2.20. Synthesis of RCM Precursor 158. 
 
Synthesis of the ring-closing metathesis precursor began with a known 
two-step sequence developed in the Smith laboratory to convert iodide 159 to 
aldehyde 160.4  Next, we investigated the Wittig olefination between ylide 161 
and aldehyde 160,19 however, conditions to effect this direct transformation were 
never realized.  We alternatively turned to a robust three step sequence, wherein   
aldehyde 160 was exposed to ylide 162 to provide an unsaturated ester.19  
Subsequent reduction to the allylic alcohol followed by oxidation yielded the 
desired aldehyde 163 in excellent yield.34  Elaboration to allylic alcohol 165 was 
accomplished using chiral borane 164 under Brown’s alkoxyallylation 
conditions.35  Ring-closing metathesis (RCM) precursor 158 was subsequently 
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synthesized by subjecting the allylation adduct 165 to neat acrolein diethyl acetal 
and a catalytic amount of mild acid.36 
2.4.3 DHP Formation 
We next investigated the RCM of the two terminal olefins in triene 158 
(Scheme 2.22).33  Various temperatures, solvents, and catalysts were screened 
for the conversion of triene 158 to closed ring product 157; unfortunately, results 
were plagued by low and inconsistent yields of the desired product.  Acceptable 
conditions were found to be a dilute solution refluxing solution of CH2Cl2 with 10 
mol% Grubbs’ 2nd generation catalyst 128, which after 4 h afforded cyclized 
adduct 157 in 59% as a mixture of diastereomers with 29% recovered starting 
material. 
Scheme 2.21 RCM of Triene 158. 
 
Our focus shifted towards the allylation of mixed acetal 157 (Scheme 
2.23).  It was believed that our desired product would be both kinetically and 
thermodynamically favored.32  Assuming that the substitution proceeds via an 
SN1 pathway, there are two possible conformations (A and B) that the transition 
state can adopt.  Attack from the bottom faces of both A and B should be 
hindered by a negative steric interaction with either the C9 or C10 substituent 
respectively.  Attack from the top faces of both conformations, however, lacks 
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this steric interaction, leading to the desired product 106.  Additionally, since C9 
or C10 heteroatom-substituted oxocarbenium ions prefer psuedoaxial 
conformations by ~4 kcal/mol due to the stabilizing interaction between the 
partially negative heteroatom and the positively charged carbon it can be 
assumed that conformation B is more densely populated.37  If the nuclephilic 
attack were to occur from the bottom face a high energy half-boat conformation 
of the DHP would result.  Conversely, unhindered approach from the top face 
leads to a more favorable half-chair conformation.  All of these factors support 
formation of DHP 106 with the requisite configuration at C13. 
Scheme 2.22. Stereochemical Rationale for the Formation of DHP 106. 
 
Our initial attempt to allylate mixed acetal 157, utilizing TMSOTf as the 
Lewis acid, instead resulted in allylation of the methoxymethyl acetal, to afford 
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166 (Entry 1, Table 2.3).  This undesired reactivity of the methoxymethyl ether 
initially indicated that an alternate protecting group for the C10 alcohol was 
required.  Fortuitously, as we attempted to cleave the MOM ether using alternate 
Lewis acidic conditions, boron trifluoride diethyl etherate in dimethyl sulfide, lactol 
167 was formed (Entry 2). This indicated that selective oxocarbenium formation 
at C13 would be possible in the presence of the methoxymethyl protecting group.  
Initial attempts employing borontrifluoride diethyl etherate as the Lewis acid and 
allyltrimethylsilane as the nucleophile produced the desired allylation product 106 
in 38% yield with a significant amount (32%) of the recovered mixed acetal (Entry 
3).  But increased amounts of the Lewis acid improved conversion and yield 
(Entries 4 and 5).  Complete conversion was achieved by allowing the reaction 
mixture to slowly warm to -45 °C after the addition  of the nucleophile (Entry 6). 
Table 2.3. Allylation Conditions for Mixed Acetal 157. 
 
Entry Lewis 
Acid 
Equiv. 
L.A. 
Nucleophile Equiv. 
Nucleophile 
Temperature Major 
Product 
Yield 
1 TMSOTf 0.5 allylTMS 20 -70 °C 166 - 
2 BF3•OEt2 1.5 SMe2 neat -70 °C 167 - 
3 BF3•OEt2 1.5 allylTMS 10 -70 °C 106 38% 
4 BF3•OEt2 5 allylTMS 10 -70 °C 106 60% 
5 BF3•OEt2 10 allylTMS 10 -70 °C 106 77% 
6 BF3•OEt2 10 allylTMS 10 -70 → -45 °C 106 92% 
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2.4.4 Structure Determination 
The stereochemistry of the newly formed dihydropyran 106 was supported 
by 2D NMR analysis.  As shown in Figure 2.4, an nOe interaction was observed 
between the protons at C9 and C10, implying a syn relationship, in addition to the 
allylic protons at C14 of the newly appended allylic moiety and the proton at C9, 
indicating an anti relationship between the C9 and C13 protons.  Further proof 
lies in the absence of an nOe interaction between the C9 and C13 protons of the 
DHP, denoting a trans relationship between the C9 and C13 substituents. 
Figure 2.4 Stereochemical Configuration Confirmation of DHP 106 via nOe Analysis. 
 
2.4.5 Elaboration 
Similar to the tetrahydropyran moiety, it was proposed that investigating 
several coupling strategies based on simple elaborations of dihydropyran 
fragment 106 would be possible.  We envisioned assembly of the six additional 
coupling fragments shown in Scheme 2.24 from dihydropyran 106.  It would then 
be possible to explore all of the coupling strategies previously mentioned with 
these seven fragments. 
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Scheme 2.23.  Coupling Fragments for the DHP Moiety and Relevant Coupling Strategies. 
 
Elaboration of dihydropyran fragment began with efforts towards alkyne 
171 (Scheme 2.24).  To this end, enyne dimer 168 was prepared from known 
aldehyde 16929 via a methylene Wittig reaction24 and subsequent exposure to 
Grubbs’ 1st generation catalyst 97.12  Cross metathesis between terminal olefin 
106 and dimer 168 to afford cross-coupled product 170 was effected with 
Grubbs’ 2nd generation catalyst 128.12  Previous attempts to effect the cross 
metathesis with the monomer had suffered from poor conversion.  The TIPS 
protected alkyne 170 was then exposed to tetrabutylammonium fluoride to yield 
desired alkyne 171 in two steps from the core synthetic fragment 106. 
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Scheme 2.24. Synthesis of Alkyne 171. 
 
Next, exposure of alkyne 171 to Lindlar’s catalyst enabled access to 
tetraene 172 in good yield (Scheme 2.25).38  Unfortunately, preliminary 
experimentation failed to provide vinyl iodide 173.39  This strategy was 
temporarily abandoned, but would be revisited should the other coupling 
strategies fail. 
Scheme 2.25. Synthesis of Tetraene 172 and Attempted Synthesis of Vinyl Iodide 173. 
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The next fragment investigated was vinyl iodide 174 (Scheme 2.26).  The 
synthesis of coupling fragment 174 was explored prior to being informed of the 
true configuration at C10 (Section 1.2.2).  While under the impression that C10-
epi-174 possessed the correct stereochemistry present in the natural product, its 
synthesis was undertaken.  Again, if other coupling strategies proved ineffective 
the synthesis of vinyl iodide 174 would be revisited. 
Scheme 2.26. Synthesis of C10-epi-174. 
 
Only preliminary experimentation was conducted towards C10-epi-174, 
and reactions were run on small scale and remain unoptimized.  In some cases 
yields were not recorded, and thus none are reported for this sequence.  To this 
end, the methoxymethyl ether was deprotected with acidic methanol to afford 
alcohol 175 and subjected to a Mitsunobu inversion with p-nitrobenzoic acid.40  
Hydrolysis of the ester with basic methanol afforded alcohol 176.  DCC 
coupling41 with known acid 177 provided vinyl iodide C10-epi-174 in four steps 
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from the core dihydropyran fragment 106.  All attempts to conduct the Mitsunobu 
inversion directly with acid 177 were impaired by an elimination pathway resulting 
in tetraene 178.  Although synthesis of dihydropyran 174 would not require a 
Mitsunobu inversion, these results suggest that esterification at the C10 allylic 
alcohol would be possible in late stage transformations. 
An additional elaboration of core dihydropyran fragment 106 accessed 
coupling fragment t-butyl ester 181 (Scheme 2.27).  A difference to note between 
these two coupling fragments and the others shown in Scheme 2.24 is that the 
oxidation state of C1 was altered from the alcohol to the acid protected as the t-
butyl ester.  With these fragments we decided to investigate the possiblility of 
incorporating the dihydropyran moiety into the molecule with the desired 
oxidation state at C1 in addition to alternate methods of coupling.  The t-butyl 
ester was chosen as a protecting group, as Jansen and co-workers showed that 
its late-stage cleavage was possible.5 
Scheme 2.27. Synthesis of t-Butyl Ester 181. 
 
In order to convert the C1 alcohol to the desired oxidation state a four step 
sequence published by Smith was applied (Scheme 2.28).4  To this end, the 
PMB ether was cleaved under oxidative conditions with DDQ followed by 
oxidation42 of the resultant alcohol to aldehyde 179.  A second oxidation43 
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followed by subjection of the crude acid to isourea 18044 afforded the desired 
ester 181 in good yield. 
As noticed during investigating of the allylation of mixed acetal 157 (Table 
2.3), cleavage of the methoxymethyl protecting group was successful with 
TMSOTf (Scheme 2.29).  On small scale (<5 mg) the reaction proceeded 
satisfactorily.  However, on larger scale (50 mg), alcohol 182 was produced in 
only 22% yield.  The DIC coupling41 of allylic alcohol 182 to α,β,γ,δ-unsaturated 
acid 183, accessed from known ester 18445 via hydrolysis, yielded the desired 
vinyl stannane 185 in an unoptimized 50% yield.  
Scheme 2.28. Completion of Vinyl Stannane 185. 
 
2.5 Summary 
In summary, the three core synthetic fragments of (+)-sorangicin A have 
been synthesized.  The bicyclic ether moiety 104 was accessed in twelve steps 
from E-cinnamaldehyde (113), the core tetrahydropyran fragment 105 was 
achieved in eight steps from 3-butenal (141), and the core dihydropyran subunit 
106 was accomplished in seven steps from known aldehyde 160 (Scheme 2.30).  
63 
 
For the investigation of alternate coupling strategies, core tetrahydropyran 150 
was prepared in four steps from core THP 105.  Also, dihydropyran 106 was 
elaborated into several additional compounds in order to assess several routes 
for the coupling and macrocyclization of all three subunits of (+)-sorangicin A. 
Scheme 2.29. Summary of the Synthesis and Elaboration of the Three Core Fragments of 
(+)-Soragnicin A 
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CHAPTER THREE 
COUPLING STRATEGIES  
 
3.1 Synthetic Strategy 
As stated in the previous chapter our synthetic approach for the synthesis 
of (+)-sorangicin A involved investigation of coupling strategies using dissimilar 
types of chemistry, all of which are accessible from the same three core 
fragments (Scheme 3.1).  As we intended to couple the three fragments with 
possible bond formations in differing locations throughout the molecule, two 
general strategies for the synthesis of the natural product emerged and are 
outlined in Scheme 3.1.  We envisioned the first coupling event involving the 
union of the bicyclic ether moiety 186 with the tetrahydropyran subunit 187 
utilizing either a cross metathesis1 or a Julia-Kocienski olefination.2  From this 
point the strategies diverged.  The first, following Path A, would investigate 
coupling a dihydropyran 189 to the tetrahydropyran portion of polycycle 188 
forming one of three different bonds; the C20-C21 σ bond, the C19-C20 double 
bond, or the C15-C16 double bond.  Should one of these couplings prove 
effective in providing the late-stage intermediate 190, macrocycle formation 
would follow via one of two cyclizations; 1) a Stille or a Suzuki-Miyaura
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coupling reaction3 to form the C38-C39 sigma bond, the C40-C41 sigma bond, or 
both in a double bond forming event, or 2) a lactonization4 between the C10 
alcohol and the C43 carbonyl. 
Scheme 3.1. General Coupling Strategies for (+)-Sorangicin A. 
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The second strategy, following Path B, involves coupling of a DHP 
fragment 191 with the polycycle 188 at the bicyclic ether portion of the molecule.  
This coupling would involve one of the previously discussed palladium-catalyzed 
couplings or an esterification between the C10 alcohol and the C43 carbonyl.  
Closure of the macrocycle would then follow via one of the previously discussed 
bond formations between C20-C21, C19-C20, or C15-C16. 
3.2 Coupling the Bicyclic Ether and THP Fragments 
3.2.1 1st Generation Cross Metathesis 
As both general coupling schemes, Path A and Path B, rely on the use of 
the common coupled bicycle/THP fragment 188 (Scheme 3.1), our coupling 
efforts began with a cross metathesis between bicyclic ether fragment 104 and 
both THP fragments 105 and 149 (Scheme 3.2).1  Altering solvent, temperature, 
reaction time, and various ruthenium-based metathesis catalysts never achieved 
a higher yield than about 35%, however, in most cases nearly all unreacted 
starting material was recovered.  
Scheme 3.2. Cross-Coupling the Bicyclic Ether Moiety and the THP Subunit. 
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It was proposed that the THP fragments 105 and 149 and their respective 
dimers were significantly more reactive towards the catalyst than the bicyclic 
ether fragment 104, and that perhaps a significant excess of the bicyclic ether 
fragment 104 when compared to the THP olefins would drive the reaction further 
toward completion.  In order to test this hypothesis THP 105 was added slowly 
with the use of a syringe pump over 4 h to a refluxing solution of olefin 104 and 
Grubbs 2nd generation catalyst 128 (Scheme 3.3).  Gratifyingly, the two 
fragments were coupled in 63% yield and nearly all starting material was 
recovered (~8% of the bicyclic fragment dimer was isolated, which is inactive 
under these metathesis conditions).  It should be noted that the first 30% of the 
THP fragment was added much faster than intended, which likely contributed to 
lower conversion, but since the reaction was performed on a relatively large 
scale (~1 mmol of each fragment), it was never repeated to attempt higher 
conversion.  Because the cross metathesis proved effective, coupling between 
the bicyclic ether moiety and the THP subunit with a Julia-Kocienski reaction was 
never investigated. 
Scheme 3.3. Optimized Cross Metathesis between the Bicyclic Ether 104 and THP 105. 
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3.2.2 2nd Generation Cross Metathesis 
In order to investigate additional late stage coupling strategies, bicyclic 
ether fragment 104 was also cross-coupled with THP subunit 150 (Scheme 3.4).  
Following small scale test reactions to confirm the new THP fragment was 
compatible with cross metathesis conditions, terminal olefin 150 was slowly 
added via syringe pump to a refluxing solution of bicyclic ether fragment 104 and 
Grubbs’ 2nd generation catalyst 128 (1 mmol of each fragment).1  These 
conditions failed to couple the two fragments in comparable conversion to the 
previous system (Scheme 3.3) as only a 40% yield of the coupled product 195 
was isolated.  However, as before, both unreacted starting materials were 
recovered in good yield. 
Scheme 3.4. Cross Metathesis between Bicyclic Ether 104 and THP 150. 
 
3.3 Coupling Strategies Following Path A 
As mentioned in section 3.1, coupling strategies following Path A form a 
bond between the DHP moiety and the THP containing terminus of the 
bicycle/THP fragment (Scheme 3.5).  Investigation of this general strategy 
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included coupling of the DHP fragment to the bicycle/THP coupled intermediate 
via both acetylide addition to an aldehyde5,6 and the cross metathesis of two 
terminal olefins.1 
Scheme 3.5. Path A Coupling Strategies. 
 
3.3.1 Acetylide Addition 
Scheme 3.6. Synthesis of Aldehyde 197. 
 
Our initial attempt to access aldehyde 197 included selective cleavage of 
the primary silyl ether at C21 in coupled product 194 (Scheme 3.6).  No selective 
conditions were identified to access alcohol 196.  Instead a non-selective 
deprotection was used with dilute HF•pyridine in THF.  Oxidation of alcohol 196 
under Swern conditions afforded aldehyde 197 in good yield.7  Efforts to oxidize 
the primary silyl ether 194 directly to aldehyde 197 resulted in a 53% yield of the 
74 
 
desired product along with 25% recovered starting material.8  Although this one-
pot procedure was superior to the two step sequence, improvement was still 
desired. 
Scheme 3.7. Coupling Alkyne 171 and Aldehyde 197. 
 
 We next explored methods for the addition of alkyne 171 to aldehyde 197 
(Scheme 3.7).  Conditions developed by Carreira for coupling a terminal alkyne 
and an aldehyde proved ineffective, regardless of altering temperature and 
equivalents of the catalytic reagents.5  Instead, we found that adding aldehyde 
197 to the lithiated acetylide of alkyne 171 provided propargyl alcohol 198 and 
unreacted starting material.  Although the addition favored one diastereomer 
(actual diastereomeric ratio not determined) its configuration remained unknown. 
According to the Felkin-Anh model, approach of the nucleophile should 
come from the bottom face of the aldehyde as shown in Scheme 3.8 affording 
the desired product α-198.9 
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Scheme 3.8. Stereochemical Model for the Addition of Lithiated Alkyne L-171 to Aldehyde 
197. 
 
Scheme 3.9.  Attempted Determination of the C21 Configuration of Alcohol 198. 
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In order to determine the configuration of the newly formed stereocenter, 
we proposed that deprotection of the C22 TBS ether followed by an 
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oxidation/reduction sequence could be informative (Scheme 3.9).  Chelation 
controlled reduction of α-hydroxyketones is known to provide the anti relationship 
that is desired in our system.10  Comparison of the deprotected addition product 
199 to the adduct of the oxidation/reduction sequence (201) should either confirm 
or refute the formation of the desired anti-diol 201. Unfortunately, α-hydroxy 
ynone 200 was not stable as 5-endo-dig cyclizations of α-hydroxy ynones are 
quite facile.11 
While investigating the newly formed stereocenter, we also were 
interested in moving the material forward.  Experimentation with the wrong 
diastereomer would serve as a model system for subsequent chemical 
transformations with the desired diastereomer.  However, we were forced to 
pursue another method for coupling the bicycle/THP moiety with the DHP 
fragment as we were unable to successfully effect reduction of the triple bond in 
coupled product 198 (Scheme 3.10).  Various conditions known to reduce 
propargyl alcohols to the trans double bond including Red-Al,12 sodium in liquid 
ammonia,13 and LiAlH414 were employed without achieving allylic alcohol 202.  
We then turned to cross metathesis as a strategy for coupling the two fragments. 
Scheme 3.10. Failed Reduction of Propargyl Alcohol 198. 
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3.3.2  Cross Metathesis 
Scheme 3.11. 1st Generation Cross Metathesis Coupling Strategy. 
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The original metathesis strategy proposed cross-coupling acetonide 203 
with tetraene 172 forming the C19-C20 double bond (Scheme 3.11).  In an 
attempt to increase the yield of the primary silyl ether, previously discussed 
cross-coupled product 193 was subjected identical oxidation conditions, but only 
a modest increase in yield was observed (Scheme 3.12).  Aldehyde 205 was 
then exposed to divinylzinc, yielding one diastereomer in high selectivity.15  A 
tandem deprotection/protection sequence then afforded acetonide 203 with 
unknown stereochemistry at C21.  Subjection of acetonide 203 and tetraene 172 
to Grubbs’ 2nd generation catalyst 128 resulted only in degradation of the DHP 
fragment 172.1  Based on these results we turned to an alternate route which 
involved a cross metathesis to form the C15-C16 double bond. 
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Scheme 3.12. Synthesis of Acetonide 203 and Attempted Cross Metathesis with Tetraene 
172. 
 
This similar strategy would involve the cross-coupling of DHP 106 and 
terminal olefin 206 as shown in Scheme 3.13.  In order to access complex 
coupling fragment 206, a simple three step sequence from acetonide 203 was 
employed. 
Scheme 3.13. 2nd Generation Cross Metathesis Coupling Strategy. 
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To this end, acetonide 203 was subjected to cross metathesis conditions 
with enyne dimer 168 using the Hoveyda-Grubbs 2nd generation catalyst 207 
(Scheme 3.14).16  Deprotection of the resultant alkyne 208 followed by reduction 
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with Lindlar’s catalyst17 under an atmosphere of hydrogen afforded cross-
coupling partner 206.  Terminal olefin 206 was then exposed to DHP 106 in the 
presence of the Hoveyda-Grubbs 2nd generation catalyst 207, which on small 
scale (4 and 6 mg respectively) produced the desired complex intermediate 204. 
Scheme 3.14. Synthesis of Cross-Coupling Partner 206 and Cross Metathesis with Olefin 
106. 
 
Prior to the cross coupling of bicyclic ether fragment 104 and THP 150 
(Scheme 3.4), the above sequence was utilized to access the protected alkyne 
208.  Comparison of alkyne 208 with the supposedly identical coupled product 
195, with known stereochemistry at C21 (Scheme 3.4), unexpectedly revealed 
that the two compounds differed.  Alkyne 208 was determined to be the C21 
epimer of cross-coupled product 195 (Figure 3.1).  This was confirmed as the 1D 
1H NMR of protected alkyne 208 corresponded with that of the minor 
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diastereomer THP 155 used to determine the stereochemical outcome of the 
vinyl zinc addition in Section 2.3.6.  
Figure 3.1. Determination of the C21 Stereochemical Configuration of Alkyne 208. 
O
Me
TBSO
O
H
H
O
27
23
19
TIPSMe
Me
O
O
OPiv
Me
30 37
O
Me
TBSO
O
H
H
O
27
23
19
TIPSMe
Me
O
O
OPiv
Me
30 37
O
Me
TBSO
O
H
H
O
27
23
19
TIPSMe
Me
O
O
OPiv
Me
30 37
X
195 208
 
The divergent diastereoselectivity between the vinylzinc addition in 
Scheme 3.12 and the vinylzinc addition discussed in the previous chapter 
(Scheme 2.17) could be due to the use of different vinyl species or aldehydes.  
However, it is most likely a solvent effect as the undesired configuration (Scheme 
3.12) is the major product in toluene, whereas, the desired configuration 
(Scheme 2.17 and coupled product 195 in Scheme 3.4) is formed selectively in 
THF. 
Scheme 3.15. 3rd Generation Cross Metathesis Coupling Strategy.  
Me Me
O
O
O
Me
TBSO
O
Me
H
H
O
OH
30 37
27
23
O
Me
Me
H
t-BuO
13 9
H
1
OMOM
Me
Me
O
O
O
Me
TBSO
O
O
OMOM
Me
Me
H
Me
H
H
t-BuO
O H
OH
30 37
27
23
19
13 9
1
+
O O
catalyst
209 181 210
 
Despite the unwanted stereochemistry at C21, the series of reactions in 
Scheme 3.14 served as a model confirming that a cross metathesis coupling 
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strategy was capable of forming the C15-C16 double bond (Scheme 3.15).  As 
cross-coupled fragment 195 possessed the correct configuration, we sought to 
unite the corresponding free alcohol 209 and t-butyl ester 181 with a cross 
metathesis reaction to afford complex intermediate 210.1  It was now necessary 
to introduce the bicyclic ether/THP fragment without the pivalate protecting 
group, due to the presence of an ester in DHP moiety.  
Scheme 3.16. Synthesis of Triene 209. 
 
To this end, cleavage of the ester protecting group followed by 
deprotection of the alkyne and subsequent reduction with Lindlar’s catalyst17 
afforded terminal olefin 209 in good yield (Scheme 3.16). 
Scheme 3.17. Cross Metathesis between Free Alcohol 209 and DHP 181. 
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With the complex coupling fragment 209 in hand, as well as DHP 181 
(Scheme 2.28), our focus turned towards the cross-coupling reaction.  
Pleasingly, our initial attempts employing the Hoveyda-Grubbs 2nd generation 
catalyst 207 were successful (Scheme 3.17).16  Yields ranged from 30-40%, 
however, unreacted alcohol 209 and its homodimer were only recovered in about 
30%. 
Once all three fragments were coupled and requisite stereocenters 
established, efforts were turned towards formation of the triene moiety and 
macrocyclization.  Treatment of alcohol 210 with Dess-Martin periodinane18 
afforded the aldehyde 211 (Scheme 3.18).  Subsequent exposure of the crude 
aldehyde to Takai olefination conditions yielded 20% of the desired E-vinyl iodide 
212.19  Although the exact diastereomeric ratio was not discernable from the 
unpurified 1H NMR, selectivity seemed to be greater than 3:1. 
Scheme 3.18.  Syntheis of Vinyl Iodide 212. 
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With access to vinyl iodide 212, we proposed the five step sequence 
shown in Scheme 3.19 to effect the completion of the natural product.  Cleavage 
of the methoxymethyl ether followed by esterification with acid 183 (from Scheme 
2.29) would yield advanced intermediate 213.  Prior to macrocyclization, the TBS 
ether would be cleaved as the triene is known to be intolerant of fluoride ions.   A 
palladium-catalyzed intramolecular coupling would close the macrocycle, which 
would require only a global deprotection to afford (+)-sorangicin A (1).  Both the 
acetonide and the t-butyl ester were removed with acid, as shown by Jansen.20 
Scheme 3.19.  Proposed Completion of (+)-Sorangicin A from Vinyl Iodide 212. 
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Unfortunately, our initial attempts to deprotect the methoxymethyl group 
with TMSOTf, encouraged by the previously described deprotection of MOM 
ether 181 (Scheme 2.28), resulted in decomposition (Scheme 3.20).  At this 
point, we chose not to further investigate this deprotection and redirected our 
efforts to an alternate coupling strategy based on the relatively robust nature of 
the cross metathesis between the DHP fragment 181 and terminal olefin 209 
(Scheme 3.17).  We proposed that prior to this coupling reaction, additional 
synthetic manipulation of the two terminal olefins would promote a more 
convergent synthesis.  Additionally, an alternate route was desired as it would 
eliminate the low yielding oxidation/Takai olefination sequence (Scheme 3.18). 
Scheme 3.20. Attempted Formation of Alcohol 214. 
 
3.4 A Coupling Strategy Following Path B 
As discussed in section 3.1, coupling strategies following Path B would 
couple the DHP moiety to the bicyclic ether terminus of the bicycle/THP coupled 
intermediate.  Scheme 3.21 details our proposed coupling of the DHP moiety and 
vinyl iodide 215, connecting all three fragments and forming the sensitive 
trieneoate moiety (218).  If the initially proposed use of vinyl stannane 216 
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proved unsuccessful, use of pinacolboranes, such as 217, are known to function 
well in vinyl/vinyl couplings.3 
Scheme 3.21. Proposed Coupling via a Palladium Catalyst. 
 
Scheme 3.22. Synthesis of Vinyl Iodide 219. 
 
To probe the above palladium-mediated coupling reaction, we first needed 
to access vinyl iodide 215 (Scheme 3.22).  Oxidation of alcohol 209 with Dess-
Martin periodinane,18 followed by exposure of the crude aldehyde to Takai 
olefination conditions19 yielded vinyl iodide 219 in 46% over two steps.  Although 
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still modest, the formation of the vinyl iodide prior to the incorporation of the DHP 
moiety was far superior to the sequence reported in Scheme 3.18. 
Finally, cleavage of the TBS ether with tetrabutylammonium fluoride 
afforded the desired vinyl iodide 215 in good yield (Scheme 3.23).  Worth noting 
is the elimination of HI from the Z-isomer in the presence of tetrabutylammonium 
fluoride.  Using Z-vinyl iodide 220 as a model system, it was discovered that 
subjection to tetrabutylammonium fluoride at 40 °C for 3 h provided alkyne 221, 
with the silyl ether intact. 
Scheme 3.23. Deprotection of Silyl Ether 219 and Elimination of HI from Vinyl Iodide 215. 
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With vinyl iodide 215 in hand, we were now able to investigate the cross-
coupling with vinyl stannane 216 (Scheme 3.24).  Gratifyingly, exposure to the 
conditions utilized by the Smith laboratory for their model system afforded the 
cross-coupled product 218 in 58% yield.21 
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Scheme 3.24.  Coupling Vinyl Iodide 215 and Vinyl Stannane 216. 
 
Scheme 3.25. Proposed Completion of (+)-Sorangicin A from Complex Intermediate 218. 
 
From complex intermediate 218 we proposed a two step sequence to 
complete the natural product (Scheme 3.25).  Use of a metathesis catalyst would 
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effect a RCM to form the macrocycle22,23 and subsequent exposure to acid to 
cleave the two remaining protecting groups would yield the natural product. 
Unfortunately, exposure of the polyene 218 to the Hoveyda-Grubbs 2nd 
generation catalyst,16 which had shown excellent E:Z selectivity in the previously 
discussed intermolecular cross-couplings, resulted in an unwanted RCM reaction 
between the terminal olefin appended to the DHP subunit and the conjugated 
triene.  The major product isolated from the reaction was an unidentified 
compound that lacked the 1H NMR signals unique to the DHP moiety. 
3.5 Summary 
Scheme 3.26. Coupling of the Bicyclic Ether Fragment 104 and Various THP Moieties. 
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To summarize the coupling efforts reported in this chapter, a cross 
metathesis reaction was used to couple the bicyclic either fragment 104 with 
various THP moieties (Scheme 3.26).  These coupled products were progressed 
based on two different coupling strategies, those following Path A and those 
following Path B (Section 3.1).  The first general coupling strategy, Path A, 
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utilized both bis-triethylsilyl ether 193, which was oxidized to aldehyde 205, and 
acetonide 150. 
The two coupling strategies involving aldehyde 205 were: direct coupling 
with alkyne 171, and its further elaboration to terminal olefin 203, and attempted 
cross metathesis with tetraene 172 (Scheme 3.27).  Although acetylide addition 
with alkyne 171 to form propargyl alcohol 198 was successful, the configuration 
of the stereocenter formed at C21 was never established and conditions to 
reduce the triple bond were never realized.  The cross metathesis between 
acetonide 203 and tetraene 172 to form the C19-C20 double bond proved 
unsuccessful as exposure to the reaction conditions resulted in DHP fragment 
degradation. 
Scheme 3.27. Coupling Attempts Utilizing Aldehyde 205. 
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Utilizing a more efficient route, protected alkyne 150 was converted to 
terminal olefin 209 in three steps, and formation of the C15-C16 double bond via 
metathesis with DHP fragment 181 was effectively executed (Scheme 3.28).  
Further elaboration of the cross-coupled product to the natural product was 
halted as the route involved prohibitively low-yielding steps and initial selective 
deprotection efforts of vinyl iodide 212 were unsuccessful.   
Scheme 3.28. Use of Cross Metathesis to Form the C15-C16 Double Bond and Further 
Elaboration. 
 
Our efforts to couple all three fragments using a route that follows Path B 
also began with protected alkyne 150 (Scheme 3.29).  In six steps pivalate 150 
was converted to vinyl iodide 215.  Palladium(II)-catalyzed cross-coupling with 
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vinyl stannane 216 successfully afforded trienoate 218, however, metathesis 
conditions failed to yield the desired ring-closed product. 
Scheme 3.29. Palladium-Mediated Cross-Coupling to Afford Trienoate 218 and Attempted 
RCM. 
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3.6 Future Direction 
Based on the experiments previously discussed in this chapter, we 
propose that completion of the (+)-sorangicin A will be possible through a simple 
reordering of steps as shown in Scheme 3.30.  Cross metathesis, prior to the 
installation of the triene, between vinyl iodide 219 and DHP fragment 182 will 
afford advanced intermediate 220.  Esterification to install the vinyl stannane 
followed by deprotection of the TBS ether should provide the macrocyclization 
precursor 221.  Exposure to the catalytic conditions previously discussed 
followed by a global deprotection is envisioned to deliver the (+)-sorangicin A. 
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Scheme 3.30. Proposed Completion of (+)-Sorangicin A. 
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Chapter Four 
Experimental 
 
4.1 Materials and Methods 
Infrared (IR) spectra were obtained using a JACSO FT/IR 460-plus 
spectrometer. Absorbances are described as weak (w), medium (m), strong (s), 
or broad (br).  Proton and carbon nuclear magnetic resonance (1H and 13C NMR) 
spectra were recorded on the following instruments: Bruker 500 (1H at 500 MHz; 
13C at 125 MHz) Bruker 400 (1H at 400 MHz; 13C at 100 MHz) and Bruker 300 
(1H at 300 MHz). Chemical shifts are reported in ppm with residual undeuterated 
solvent peaks as internal reference for 1H NMR: CHCl3 (7.26 ppm) and 
deuterated solvent shifts for 13C NMR: CDCl3 (77.0). Multiplicities are reported as 
(s) singlet, (d) doublet, (t) triplet, (q) quartet and (m) multiplet.  Unresolved, 
overlapping resonances are reported as “band”.  Coupling constants (J) are 
given in Hz. Optical rotations were determined using a JACSO P1010 
polarimeter. Mass spectra were obtained using a Micromass Quattro II (triple 
quad) instrument with nanoelectrospray ionization. Thin layer chromatography 
(TLC) was conducted on silica gel 60 F254 TLC plates purchased from Dynamic 
Adsorbents. Flash chromatography was carried out using silica gel (60 Å, 40 to 
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63 µm) purchased from Dynamic Adsorbents. Diethyl ether (Et2O), 
tetrahydrofuran (THF), dichloromethane (CH2Cl2), and toluene were dried by 
passing through a column of neutral alumina under nitrogen immediately prior to 
use. Alkylamines and benzene were distilled from calcium hydride immediately 
prior to use. Magnesium bromide diethyl etherate was used as received from 
Aldrich Chemical Co. and stored in a glove box.  Titanium (IV) isopropoxide was 
distilled under reduced pressure and stored in a desiccator.  Acetic anhydride 
was distilled and stored under a blanket of argon.  Pivaloyl chloride was distilled 
and stored over 4Å molecular sieves.  Dess-Martin periodinane was prepared 
according to literature procedures and stored at -20 ºC.  t-butyl alcohol was 
distilled over sodium metal.  All other reagents and solvents were used as 
received from the manufacturer. All air and water sensitive reactions were 
performed under a positive flow of argon in flame dried flasks. 
4.2 Procedures 
 
 
To MgBr2·Et2O (1.46 g, 5.65 mmol) was added EtOAc (100 mL,  HPLC 
grade), the propionylthiazolidinethione (10.0 g, 37.7 mmol), distilled 
cinnamaldehyde (5.22 mL, 41.4 mmol), distilled triethylamine (10.5 mL, 75.4 
mmol), and distilled TMSCl (7.22 mL, 56.5 mmol).  The milky yellow reaction 
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mixture was stirred for 40 h.  The reaction mixture was then filtered through a 
plug of silica gel and flushed with Et2O.  The eluent was evaporated and purified 
via flash chromatography (2% EtOAc/hexanes/trace triethylamine) to yield 14.6 g 
of the aldol-adduct (83%). 1H NMR (400 MHz, CDCl3)  δ 7.38-7.20 (band, 10H), 
6.55 (d, J = 16.0, 1H), 6.08 (dd, J = 16.0, 8.0, 1H), 5.10 (ddd, J = 10.6, 6.7, 3.8, 
1H), 4.47 (dd, J = 8.6, 1H), 4.34 (dddd, J = 9.1, 6.7, 6.7, 6.7, 1H), 3.36-3.27 
(band, 2H), 3.09 (dd, J = 13.2, 10.8, 1H), 2.92 (d, J = 11.4, 1H), 1.18 (d, J = 6.7, 
3H), 0.08 (s, 9H);  13C NMR (100 MHz, CDCl3) δ 201.10, 177.93, 136.77, 136.38, 
132.57, 130.10, 129.46, 128.92, 128.64, 127.91, 127.15, 126.55, 78.48, 69.41, 
46.37, 36.55, 32.95, 14.09, 0.45;  IR (thin film) ν 3027(m), 2957(m), 1950(w), 
1880(w), 1811(w), 1697(s), 1494(m), 1453(m), 1363(s), 1342(s), 1292(m), 
1262(s), 1226(m), 1190(s), 1166(s), 1137(m), 1111(m), 1053(s); [α]22D = +310 (c 
= 1.4, CH2Cl2). 
 
 
A solution of the thione (500 mg, 1.06 mmol) in CH2Cl2 (8.5 mL) was 
cooled to -78 °C. A solution of i-Bu2AlH in hexanes (~1M) was added dropwise 
until the yellow color disappeared (1.2 mL, ~1.2 mmol).  A saturated solution of 
sodium potassium tartrate (4 mL) was added and the mixture was stirred and 
warmed to rt.  Water (10 mL) and CH2Cl2 (10 mL) were added and the 
98 
 
heterogeneous mixture was stirred vigorously for 1 h.  The layers were separated 
and the aqueous layer was extracted with CH2Cl2 (2x).  The organic solution was 
dried (Na2SO4) and evaporated. The crude oil was brought up in hexanes, 
whereupon (S)-4-(phenylmethyl)-2-thiazolidinethione precipitated as a white 
solid.  The solid was filtered off and washed with additional hexanes.  The 
combined hexanes solution was evaporated and purified via flash 
chromatography (5% EtOAc/hexanes/trace triethylamine) to yield 200 mg of the 
aldehyde (76%).  1H NMR (300 MHz, CDCl3) δ 9.81 (d, J = 2.3, 1H), 7.42-7.22 
(band, 5H), 6.58 (d, J = 15.9, 1H), 6.20 (dd, J = 15.9, 7.0, 1H), 4.48 (dd, J = 6.9, 
6.9, 1H), 2.60 (ddddd, J = 4x7.0, 2.3, 1H), 1.08 (d, J = 7.0, 3H), 0.15 (s, 9H); 13C 
NMR (100 MHz, CDCl3) δ 204.30, 136.31, 131.46, 129.93, 128.58, 127.80, 
126.47, 75.02, 52.45, 10.67, 0.24; IR (thin film) ν 3028(w), 2959(m), 2876(w), 
2727(w), 1948(w), 1877(w), 1803(w), 1729(s), 1496(w), 1450(w), 1252(s), 
1124(m), 1061(s); [α]22D = +87 (c = 2.9, CH2Cl2); MS (ESI) calculated for 
C15H22O2Si [M+Na]+: 285.1, found 285.1. 
 
Me
O
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 (-)-α-Pinene (1.36 mL, 8.54 mmol) was added to THF (1.1 mL).  The 
reaction flask was placed in a rt water bath and BH3·SMe2 (0.34 mL, 3.56 mmol) 
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was added while rapidly stirring the solution.  Stirring was ceased immediately 
following addition and the reaction mixture was allowed to stand for 18 h.  The 
reaction mixture was cooled to 0 °C, after 1 h the supernatant liquid was then 
transferred via cannula out of the flask and the remaining white crystals were 
washed with distilled pentanes (2 x 5 mL).  The crystals were dried under high 
vacuum for 0.5 h (0.950 g, 3.32 mmol), and brought up in 1.8 mL ether and the 
solution cooled to 4 °C.  Methanol (0.135 mL, 3.32 mmol) was added slowly as to 
not increase the temperature above 7 °C.  The react ion mixture was stirred at 0 
°C until no white solids remained (~2 h).  Allyl ma gnesium bromide (3.32 mL of 
1M solution in Et2O) was added dropwise.  Following addition, the reaction was 
stirred for 1 h at rt then cooled to -78 °C.  The a ldehyde (200 mg, 0.76 mmol) in 
ether (2 mL) was cooled to -78 °C and added dropwis e to the reaction over 15 
min with a jacketed addition funnel.  The reaction was complete after 15 min 
according to NMR analysis.  A mixture of 3N NaOH and 30% H2O2 (1 mL, 1:2) 
was added and the reaction mixture was heated to reflux for 4 h.  Water (10 mL) 
and ether (10 mL) were added to the solution and the phases were separated. 
The aqueous layer was extracted with ether (3 x 10 mL).  The organics were 
combined and the solvent was evaporated.  To a solution of the crude oil in THF 
(5 mL) was added 10% HCl (1 mL) and stirred for 1 h. Water (10 mL) and ether 
(10 mL) were added to the solution and the phases were separated. The 
aqueous layer was extracted with ether (3 x 10 mL).  The organics were 
combined, dried (MgSO4), and the solvent evaporated.  The crude oil was 
purified via flash chromatography (40% EtOAc/hexanes) to yield 159 mg of the 
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diol (90%) as a colorless oil.  1H NMR (400 MHz, CDCl3) δ 7.40-7.23 (m, 5H), 
6.58 (d, J = 15.9, 1H), 6.21 (dd, J = 15.9, 7.7, 1H), 5.89 (m, 1H), 5.20-5.16 (band, 
2H), 4.29 (dd, J = 7.8, 7.8, 1H), 3.69 (ddd, J = 8.3, 8.3, 3.1, 1H), 3.46 (bs, 1H), 
3.15 (bs, 1H), 2.54-2.42 (dm, J = 14.1, 2H), 2.19 (ddd, J = 15.5, 8.2, 8.2, 1H), 
1.77 (dq, J = 15.1, 7.0, 1H), 0.84 (d, J = 6.9, 3H); 13C NMR (100 MHz, CDCl3) δ 
136.44, 134.24, 131.80, 130.52, 128.39, 127.56, 126.35, 118.46, 77.84, 74.81, 
43.28, 39.40, 12.85; IR (thin film) ν 3334(br), 3079(m), 3027(m), 2975(s), 
2899(s), 1950(w), 1875(w), 1816(w), 1640(w), 1494(m), 1449(m), 1435(m), 
1378(w), 1330(m), 1109(m); [α]23D = -31 (c = 2.0, CH2Cl2); MS (ESI) calculated 
for C15H20O2 [M+H]+: 233.2, found 232.9. 
 
OH
Me
OH O
Me
O
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To a solution of diol the (236 mg, 1.02 mmol) in dry benzene (10 mL) was 
added p-methoxyphenyl dimethyl acetal (0.34 mL, 2.04 mmol) and a spatula tip 
of pyridinium p-toluenesulfonate.  The homogeneous solution was stirred for 1.5 
h.  Ether (20 mL) and saturated NaHCO3 (20 mL) were added and the mixture 
was extracted with ether (2x).  The combined organics was dried (Na2SO4), 
evaporated, and purified via flash chromatography (5% EtOAc/hexanes) to yield 
337 mg of the white crystalline acetal (94%).  1H NMR (400 MHz, CDCl3) δ 7.42-
101 
 
7.21 (band, 5H), 7.19 (AB, νAB = 233, J = 8.6, 4H), 6.80 (d, J = 15.9, 1H), 6.24 
(dd, J = 15.9, 7.6, 1H), 6.03 (dddd, J = 17.1, 10.2, 6.9, 6.9, 1H), 5.62 (s, 1H), 
5.16-5.10 (band, 2H), 4.07 (dd, J = 9.4, 9.4, 1H), 3.80 (s, 3H), 3.61 (ddd, J = 9.9, 
7.1, 3.1, 1H), 2.62-2.52 (band, 2H), 2.38 (ddd, J = 14.5, 7.1, 7.1, 1H), 1.72 (ddq, 
J = 10.0, 10.0, 6.7, 1H), 0.88 (d, J = 6.7, 3H); 13C NMR (100 MHz, CDCl3) δ 
159.82, 136.50, 134.55, 133.36, 131.23, 128.49, 127.78, 127.66, 127.48, 126.57, 
116.85, 113.53, 100.26, 83.61, 81.62, 55.26, 37.96, 37.24, 12.21; IR (thin film) ν 
2975(m), 2933(m), 2906(m), 2837(s), 2032(w), 1953(w), 1889(w), 1803(w), 
1615(s), 1518(s), 1495(m), 1452(m), 1430(m), 1397(s), 1367(m), 1337(s), 
1302(s), 1250(s), 1172(s), 1135(s), 1073(s), 1035(s), 1002(s); [α]25D = +5.9 (c = 
1.6, CH2Cl2); MS (ESI) calculated for C23H26O3 [M+H]+: 350.18, found 350.3. 
 
 
 
To a solution of the terminal olefin (0.046 mg, 0.13 mmol) in degassed 
CH2Cl2 (5 mL) was added distilled ethyl acrylate (0.315 mL, 2.89 mmol) and the 
Grubbs second generation catalyst [Cl2(Cy3P)(IMes)Ru=CHPh] (6.0 mg, 0.007 
mmol).  The solution was allowed to stir for 14 h at rt and then exposed to air for 
several hours.  The solvent was evaporated the crude black oil was purified via 
column chromatography (7.5% EtOAc/hexanes) to yield 53 mg of the white 
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crystalline enonoate (95%).  1H NMR (400 MHz, CDCl3) δ 7.42-7.22 (band, 5H), 
7.19 (AB, νAB = 228.1, J = 8.7, 4H), 7.13 (ddd, J = 15.7, 7.3, 7.3, 1H), 6.69 (d, J = 
15.9, 1H), 6.23 (dd, J = 15.9, 7.6, 1H), 5.63 (s, 1H), 4.21 (q, J = 7.1, 2H), 4.08 
(dd, J = 9.6, 7.9, 1H), 4.05 (s, 3H), 3.69 (ddd, J = 10.1, 7.2, 3.0, 1H), 2.73-2.64 
(band, 1H), 2.53 (ddd, J = 15.0, 7.2, 7.2, 1H), 1.70 (ddq, J = 10.0, 10.0, 6.6, 1H), 
1.31 (t, J = 7.1, 3H), 0.89 (d, J = 6.8, 3H); 13C NMR (100 MHz, CDCl3) δ 166.21, 
159.75, 144.63, 136.24, 133.45, 130.74, 128.38, 127.73, 127.36, 127.17, 126.45, 
123.45, 113.41, 100.17, 83.40, 80.59, 60.09, 55.13, 37.98, 35.50, 14.12, 12.11; 
IR (thin film) ν 2977(m), 2934(m), 2903(m), 2838(m), 2032(w), 1954(w), 1893(w), 
1715(s), 1655(m), 1615(m), 1518(s), 1453(m), 1398(m), 1367(m), 1303(s), 
1251(s), 1173(s), 1138(s), 1073(s), 1035(s); [α]24D = +30 (c = 1.1, CH2Cl2); MS 
(ESI) calculated for C26H30O5 [M+H]+: 422.2, found 422.2. 
 
 
A solution of the enoate (550 mg, 1.30 mmol) in CH2Cl2 (22 mL) was 
cooled to -78 °C.  A solution of i-Bu2AlH in hexanes (3.90 mL, ~1 M) was added 
and the reaction mixture was stirred for 15 min.  The reaction mixture was 
quenched with acetone (10 mL).  A saturated solution of sodium potassium 
tartrate (10 mL) was added.  The heterogeneous mixture was warmed to rt and 
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stirred vigorously for 4 h.  The mixture was extracted with ether (3x).  The 
combined organics was dried (Na2SO4) and concentrated in vacuo.  The crude 
product was purified via flash chromatography (40% EtOAc/hexanes) to yield 462 
mg of the white crystalline allylic alcohol (93%).  1H NMR (400 MHz, CDCl3) δ 
7.42-7.20 (band, 5H), 7.19 (AB, νAB = 229, J = 8.7, 4H), 6.67 (d, J = 15.9, 1H), 
6.22 (dd, J = 15.9, 7.6, 1H), 5.90 (ddd, J = 15.5, 6.9, 6.9, 1H), 5.75 (ddd, J = 
15.5, 5.8, 5.8), 5.61 (s, 3H), 4.13 (d, J = 5.3, 2H), 4.06 (dd, J = 9.7, 7.8, 1H), 3.80 
(s, 3H), 3.59 (ddd, J = 9.9, 7.0, 2.9, 1H), 2.60-2.50 (band, 1H), 2.37 (ddd, J = 
14.4, 7.3, 7.3, 1H), 1.69 (ddq, J = 10.0, 10.0, 6.7, 1H), 1.28 (bs, 1H), 0.87 (d, J = 
6.7, 3H); 13C NMR (100 MHz, CDCl3) δ 159.69, 136.31, 133.26, 131.27, 130.99, 
128.41, 128.34, 127.65, 127.40, 127.33, 126.42, 113.39, 100.14, 83.44, 81.46, 
63.54, 55.11, 37.78, 35.43, 12.09; IR (thin film) ν 3408(br), 2962(m), 2929(s), 
2841(s), 2032(w), 1954(w), 1889(w), 1614(s), 1590(w), 1518(s), 1496(w), 
1452(m), 1426(m), 1398(s), 1338(s), 1303(s), 1250(s), 1172(s), 1073(s), 1033(s); 
[α]23D = +15 (c = 0.97, CH2Cl2); MS (ESI) calculated for C24H28O4 [M+H]+: 380.2, 
found 380.2. 
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A solution of Ti(O-i-Pr)4 (0.662 mL, 0.2.24 mmol) in CH2Cl2 (1 mL) was 
cooled to -78 °C.  To this solution was added (+)-d iethyl tartrate (0.460 mL, 2.68 
mmol) and the allylic alcohol (851 mg, 2.24 mmol).  A solution of t-BuOOH in 
CH2Cl2 (5.96 mL, 17.9 M) was cooled to -20 °C and added v ia syringe to the 
reaction.  After 14 h additional t-BuOOH was added (3.73 mL, 11.2 M).  After 16 
h the reaction was quenched with NaOH in brine (10 mL, 30% w/v).  This solution 
was stirred for 1 h at 0°C, extracted with ether (3  x 10 mL).  The combined 
organics were dried over Na2SO4, evaporated en vaccuo, and purified via column 
chromatography (40% EtOAc/hexanes) to yield 864 mg of the white crystalline 
epoxy alcohol (97%).  1H NMR (400 MHz, CDCl3) δ 7.42-7.23 (band, 5H), 7.19 
(AB, νAB = 227.4, J = 8.6, 4H), 6.69 (d, J = 15.9, 1H), 6.25 (dd, J = 15.9, 7.5, 1H), 
5.64 (s, 3H), 4.07 (dd, J = 9.3, 8.1, 1H), 3.89 (d, J = 12.4, 1H), 3.80 (s, 3H), 3.70 
(ddd, J = 9.6, 6.2, 3.2, 1H), 3.66-3.59 (band, 1H), 3.28 (m, 1H), 2.99 (m, 1H), 
2.12-1.91 (band, 3H), 1.87 (ddq, J = 9.8, 9.8, 6.6, 1H), 0.89 (d, J = 6.7, 3H); 13C 
NMR (100 MHz, CDCl3) δ 159.883, 136.38, 133.50, 130.96, 128.46, 127.79, 
127.44, 127.35, 126.54, 113.56, 100.32, 83.68, 79.83, 61.82, 57.66, 55.22, 
52.78, 37.87, 34.59; IR (thin film) ν 3445(br), 2966(m), 2932(m), 2839(m), 
2032(w), 1958(w), 1889(w), 1802(w), 1614(s), 1589(w), 1518(s), 1495(w), 
1453(m), 1400(s), 1338(s), 1303(s), 1250(s), 1173(s), 1137(s), 1075(s), 1033(s); 
[α]23D = +0.87 (c = 1.2, CH2Cl2); MS (ESI) calculated for C24H28O5 [M+H]+: 
396.19, found 396.2. 
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A solution of the epoxyl alcohol (864 mg, 2.18 mmol) in CH2Cl2 (11 mL) 
was cooled to 0 °C.  Triethylamine (0.911 mL, 6.53 mmol), N,N-
dimethylaminopyridine (18 mg, 0.147 mmol), and toluenesulfonyl chloride (623 
mg, 3.27 mmol) were added and the reaction mixture was stirred for 2 h at 0 °C.  
Saturated NH4Cl (10 mL) was added to the mixture and it was extracted with 
CH2Cl2 (3 x 10 mL).  The combined organics were concentrated and dissolved in 
THF (5 mL) and MeOH (5 mL) and NaOH(aq) (5 mL) was added and stirred for 5 
min. CH2Cl2 (10 mL) was added and the phases were separated.  The aqueous 
phase was extracted with CH2Cl2 (3 x 10 mL).  The combined organics were 
concentrated and the crude oil purified via flash chromatography (20% 
EtOAc/hexanes) to yield 1.15 g of the tosylate (2.09 mmol, 96%).  1H NMR (400 
MHz, CDCl3) δ 7.55 (AB, νAB = 189.0, J = 8.2, 4H), 7.40-7.23 (band, 5H), 7.17 
(AB, νAB = 220.9, J = 8.6, 4H), 6.67 (d, J = 15.9, 1H), 6.22 (dd, J = 15.9, 7.6, 1H), 
5.62 (s, 3H), 4.21 (dd, J = 11.3, 3.7, 1H), 4.05 (dd, J = 9.5, 7.8, 1H), 3.95 (dd, J = 
11.3, 6.1, 1H), 3.80 (s, 3H), 3.75 (dd, J = 6.4, 6.2, 2H), 3.69, (ddd, J = 9.8, 6.4, 
3.2, 1H), 3.12 (m, 1H), 3.06 (m, 1H), 2.43 (s, 3H), 2.02-1.75 (band, 5H), 0.85 (d, 
J = 6.6, 3H); 13C NMR (100 MHz, CDCl3) δ 159.80, 144.88, 136.23, 133.48, 
132.43, 130.77, 129.75, 128.37, 127.80, 127.72, 127.35, 127.13, 126.87, 126.44, 
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113.46, 100.22, 83.54, 79.49, 70.09, 67.80, 55.13, 53.81, 53.45, 37.77, 34.24, 
25.43, 21.47, 12.15; IR (thin film) ν 2966(w), 2931(w), 2836(w), 1614(w), 
1598(w), 1518(m), 1495(w), 1452(w), 1400(w), 1363(s), 1342(m), 1304(w), 
1250(s), 1190(s), 1176(s), 1136(w), 1096(m), 1076(m), 1032(m); [α]23D = -6.6 (c 
= 2.0, CH2Cl2); MS (ESI) calculated for C31H34O7S [M+H]+: 550.2, found 550.2. 
 
 
 
To a solution of the tosylate (40 mg, 0.073 mmol) in THF (2 mL) was 
added 10% HCl (1 mL).  Methanol (~3 mL) was added to the cloudy mixture until 
it became clear.  The reaction mixture was stirred at rt for 18 h.  To the reaction 
mixture was added 10% NaOH (~1 mL) until it became basic.  After 5 min 10% 
HCl (~1 mL) was added until the solution became acidic and the reaction mixture 
was stirred for 4 h.  The reaction was extracted with CH2Cl2 (3x), dried (MgSO4), 
and purified via flash chromatography (50% EtOAc/hexanes)  to yield 12 mg of 
the bicyclic ether (62%).  1H NMR (400 MHz, CDCl3) δ 7.40-7.20 (m, 5H), 6.58 (d, 
J = 15.8, 1H), 6.12 (dd, J = 15.8, 7.5, 1H), 4.45 (s, 1H), 4.32 (d, J = 6.6, 1H), 
4.12-4.01 (band, 3H), 3.96 (m, 1H), 2.08 (ddd, J = 11.7, 6.6, 2.6, 1H), 1.96-1.93 
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(band, 2H), 1.54 (dq, J = 6.8, 6.8, 1H), 0.94 (d, J = 6.7, 3H); 13C NMR (100 MHz, 
CDCl3) δ 136.30, 132.34, 128.86, 128.34, 127.58, 126.36, 82.71, 79.61, 78.79, 
74.26, 60.80, 41.50, 38.63, 15.09; IR (thin film) ν 3415(br), 2962(s), 2931(s), 
2875(s), 2245(w), 1494(m), 1450(s), 1374(m), 1343(m), 1220(m), 1144(s), 
1106(m), 1031(s), 1007(s); [α]22D = -42 (c = 0.58, CH2Cl2); MS (ESI) calculated 
for C16H20O3 [M+H]+: 260.33, found 260. 
 
 
 
To a solution of the alcohol (93 mg, 0.357 mmol) in CH2Cl2 (3 mL) was 
added DMAP (4.4 mg, 0.0357 mmol) and cooled to 0 °C .  Then freshly distilled 
trimethylacetyl chloride (0.066 mL, 0.536 mmol) was added followed by 
triethylamine (0.25 mL, 1.79 mmol).  The solution was stirred at 0 °C for 1 h and 
quenched by addition of NH4Cl(aq) (2 mL).  The reaction mixture was diluted with 
CH2Cl2 (10 mL) and water (10 mL) and the organic phase separated followed by 
extraction of the aqueous phase with CH2Cl2 (2 x 10 mL).  The combined 
organics were dried over sodium sulfate, solvent was evaporated, and the 
resultant crude oil was purified via column chromatography (30% 
EtOAc/hexanes) to yield 0.115 g of the ester (0.334 mmol, 94%) as a colorless 
oil.  1H NMR (400 MHz, CDCl3) δ ppm 7.37 ppm 7.37 (d, J=7.21 Hz, 2 H) 7.29 (t, 
J=7.40 Hz, 2 H) 7.22 (m, 1 H) 6.59 (d, J=15.94 Hz, 1 H) 6.11 (dd, J=15.56, 7.59 
Hz, 1 H) 4.50 (dd, J=11.39, 6.45 Hz, 1 H) 4.41 (m, 2 H) 4.30 (d, J=6.45 Hz, 1 H) 
O
O OHMe
Ph
O
O OPivMe
Ph
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4.09 (m, 1 H) 4.04 (d, J=8.35 Hz, 1 H) 2.04 (ddd, J=11.77, 6.45, 2.66 Hz, 1 H) 
1.93 (dd, J=11.77, 1.52 Hz, 1 H) 1.51 (m, 1 H) 1.22 (s, 9 H) 0.93 (d, J=6.83 Hz, 3 
H); 13C NMR (101 MHz, CDCl3) δ ppm 178.17, 136.35, 132.50, 128.77, 128.35, 
127.57, 126.39, 80.19, 79.55, 78.98, 74.67, 62.35, 41.46, 38.58, 38.49, 27.06, 
15.05; IR (thin film) ν 3028 (w), 2967 (m), 2935 (m), 2903 (m), 2872 (m), 1729 
(s), 1480 (m), 1450 (m),1399 (w), 1366 (w), 1345 (w), 1285 (m), 1221 (w), 1145 
(s); [α]21D = -23 (c = 0.34, CH2Cl2); MS (ESI) calculated for C21H28O4[M+H]+: 
344.2, found 344.2. 
 
 
 
 
A solution of the ester (1.12 g, 3.25 mmol) in methanol (32.5 mL) was 
cooled to -70 °C and ozone was bubbled through the solution until it turned blue, 
indicating saturation.  Oxygen was then bubbled through the solution for 15 min 
followed by addition of dimethylsulfide (4.78 mL, 65 mmol).  The reaction mixture 
was allowed to warm to rt and stir overnight.  Volatiles were removed en vaccuo 
and the crude aldehyde was taken on without purification.   
To a solution of potassium tert-butoxide (1.46 g, 13.0 mmol) in THF (32 
mL), cooled to 0 °C, was added methyltriphenylphosp honium bromide ( 5.80 g, 
16.3 mmol) and stirred for 0.5 h.  A solution of the crude aldehyde was dissolved 
O O OPivMe
O
O OPivMe
Ph
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in THF (8 mL) and added slowly.  The solution was allowed to stir for 1 h at 0 °C 
then quenched with aqueous ammonium chloride (10 mL)  followed by addition of 
CH2Cl2 (40 mL) and water (20 mL).  The phases were separated and the 
aqueous layer was extracted with CH2Cl2 (2 x 20 mL).  The combined organics 
were dried over sodium sulfate, evaporated en vaccuo, and purified via column 
chromatography (30% EtOAc/hexanes) to yield 0.790 g of the terminal olefin 
(2.92 mmol, 90%, 2 steps) as colorless oil. 1H NMR (500 MHz, CDCl3) δ ppm 
5.74 (ddd, J=17.30, 9.97, 7.56 Hz, 1 H) 5.24 (d, J=16.73 Hz, 1 H) 5.16 (d, 
J=10.31 Hz, 1 H) 4.40 (m, 3 H) 4.27 (d, J=6.42 Hz, 1 H) 4.07 (m, 1 H) 3.84 (t, 
J=8.36 Hz, 1 H) 2.02 (ddd, J=11.57, 6.64, 2.41 Hz, 1 H) 1.89 (d, J=11.68 Hz, 1 
H) 1.42 (m, 1 H) 1.21 (s, 9 H) 0.89 (d, J=6.87 Hz, 3 H); 13C NMR (126 MHz, 
CDCl3) δ ppm 178.37, 137.65, 117.45, 80.35, 80.01, 79.09, 74.71, 62.52, 41.14, 
38.72, 38.57, 27.17, 15.02; IR (thin film) ν 2968 (m), 2935 (m), 2903 (m), 2876 
(m), 1732 (s), 1645 (w), 1481 (m), 1459 (m), 1397 (w), 1366 (w), 1285 (m), 1222 
(m), 1146 (s), 1079 (m), 1063 (m); [α]24D = -80 (c = 1.2, CH2Cl2); MS (ESI) 
calculated for C15H24O4[M+H]+: 268.17, found 268.16. 
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A solution of the propionate (5.00 g, 18.8 mmol) in CH2Cl2 (165 mL) was 
cooled to 0 °C and titanium (IV) chloride (2.17 mL,  19.8 mmol) was added slowly 
then stirred for 20 min.  (-)-Sparteine (4.33 mL, 18.8 mmol) was slowly added 
and the reaction mixture was cooled to -70 °C and s tirred for 20 min.  N-
Methylpyrrolidinone (1.81 mL, 18.8 mmol) was added slowly and stirred for 20 
min.  then a solution of 3-butenal in CH2Cl2 (56 mL, ~1 M) was added via cannula 
over 15 min and stirred at -70 °C for 3 h.  The rea ction mixture was then placed 
in a 0 °C ice bath and stirred for 10 min after whi ch it was quenched with 
aqueous ammonium chloride (100 mL).  The phases were separated and the 
aqueous layer was extracted with CH2Cl2 (2 x 50 mL).  The combined organics 
were dried over sodium sulfate, evaporated and purified via column 
chromatography (10% EtOAc/hexanes) to afford 6.00 g of the aldol adduct (17.9 
mmol, 95%) as a bright yellow oil. 1H NMR (500 MHz, CDCl3) δ ppm 7.34 (m, 2 
H) 7.28 (m, 3 H) 5.79 (m, J=17.13, 9.97, 7.30, 7.30 Hz, 1 H) 5.34 (ddd, J=10.37, 
6.82, 3.90 Hz, 1 H) 5.13 (m, 2 H) 4.50 (dd, J=6.64, 3.44 Hz, 1 H) 4.00 (m, 1 H) 
3.39 (dd, J=11.11, 6.99 Hz, 1 H) 3.21 (dd, J=13.06, 2.98 Hz, 1 H) 3.04 (dd, 
J=12.83, 10.77 Hz, 1 H) 2.90 (d, J=11.46 Hz, 1 H) 2.31 (m, 1 H) 2.22 (m, 1 H) 
1.27 (d, J=6.87 Hz, 3 H); 13C NMR (126 MHz, CDCl3) δ ppm 201.22, 177.98, 
136.33, 134.17, 129.42, 128.92, 127.27, 118.23, 71.53, 68.76, 42.69, 38.84, 
36.72, 32.05, 10.70; IR (thin film) ν 3445 (br), 3076 (w), 3026 (w), 2977 (w), 2926 
(m), 2854 (w), 1690 (s), 1642 (m), 1496 (w), 1455 (m), 1438 (w), 1362 (m), 1341 
(s), 1319 (m), 1292 (m), 1260 (s), 1192 (m), 1165 (s), 1136 (m); [α]24D = -32 (c = 
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0.20, CH2Cl2); MS (ESI) calculated for C17H21NO2S2 [M+H]+: 335.10, found 
335.09. 
 
 
 
 
A solution of the aldol adduct (5.34 g, 15.9 mmol) in CH2Cl2 (160 mL) was 
cooled to -70 °C and 2,6-lutidine (7.40 mL, 63.6 mm ol) was added followed by 
dropwise addition of tert-butyldimethylsilyl triflate (7.31 mL, 31.8 mmol).  The 
reaction mixture was stirred for 20 min. at -70 °C then placed in a 0 °C ice bath 
for 30 min.  The reaction was quenched with aqueous sodium bicarbonate (100 
mL) and diluted with water (100 mL).  The phases were separated and the 
aqueous later was extracted with CH2Cl2 (2 x 50 mL).  The combined organics 
were dried over magnesium sulfate, evaporated en vaccuo, and purified via 
column chromatography (5% EtOAc/hexanes) to yield 7.01 g of the silyl ether 
(15.6 mmol, 98%) as a bright yellow oil. 1H NMR (400 MHz, CDCl3) δ ppm 7.31 
(m, 5 H) 5.82 (m, J=17.12, 10.03, 7.30, 7.30 Hz, 1 H) 5.21 (ddd, J=10.43, 6.85, 
3.59 Hz, 1 H) 5.04 (m, 2 H) 4.46 (quin, J=6.52 Hz, 1 H) 4.09 (q, J=5.87 Hz, 1 H) 
3.31 (dd, J=11.41, 6.85 Hz, 1 H) 3.25 (dd, J=13.37, 3.59 Hz, 1 H) 3.03 (dd, 
J=13.04, 10.43 Hz, 1 H) 2.88 (d, J=11.74 Hz, 1 H) 2.30 (m, 2 H) 1.24 (d, J=6.85 
Hz, 3 H) 0.88 (s, 9 H) 0.05 (d, J=8.15 Hz, 6 H); 13C NMR (101 MHz, CDCl3) δ 
ppm 200.67, 176.60, 136.61, 134.51, 129.47, 128.88, 127.16, 117.17, 73.59, 
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69.23, 44.25, 40.47, 36.58, 31.88, 25.77, 18.03, 12.98, -4.11, -4.76; IR (thin film) 
ν 3065 (w), 3026 (w), 2953 (m), 2929 (m), 2887 (w), 2856 (m), 1693 (s), 1471 
(w), 1456 (w), 1362 (m), 1340 (m), 1292 (w), 1256 (s), 1190 (m), 1165 (m); [α]24D 
= -160 (c = 1.1, CH2Cl2); MS (ESI) calculated for C23H35NO2S2Si [M+H]+: 449.19, 
found 449.19. 
 
 
 
 
The terminal olefin (0.500 g, 1.12 mmole) was dissolved in CH2Cl2 (10 mL) 
and refluxed under a positive flow of argon for 20 min.  After cooling to room 
temperature freshly distilled ethyl acrylate (0.611 mL, 5.60 mmol) was added and 
Grubbs’ 2nd generation catalyst (47.2 mg, 0.0556 mmol) was added.  The 
reaction refluxed for 16 h then all volatiles were removed en vaccuo and the 
crude oil was purified via column chromatography (7.5% EtOAc/hexanes) to yield 
0.516 g of the enoate (0.989 mmol, 88%) as a bright yellow oil.  1H NMR (500 
MHz, CDCl3) δ ppm ppm 7.32 (m, 5 H) 6.93 (dt, J=15.58, 7.79 Hz, 1 H) 5.81 (d, 
J=15.58 Hz, 1 H) 5.23 (m, 1 H) 4.52 (quin, J=6.36 Hz, 1 H) 4.18 (q, J=7.10 Hz, 2 
H) 4.13 (q, J=5.42 Hz, 1 H) 3.35 (dd, J=11.46, 7.10 Hz, 1 H) 3.24 (dd, J=12.94, 
3.09 Hz, 1 H) 3.03 (m, 1 H) 2.88 (d, J=11.46 Hz, 1 H) 2.47 (t, J=6.19 Hz, 2 H) 
1.26 (m, 6 H) 0.89 (s, 9 H) 0.05 (d, J=5.73 Hz, 6 H); 13C NMR (126 MHz, CDCl3) 
δ ppm 200.90, 175.98, 166.01, 145.11, 136.50, 129.45, 129.41, 128.88, 128.83, 
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127.19, 123.68, 73.27, 69.13, 60.25, 44.60, 38.59, 36.54, 31.80, 25.73, 17.97, 
14.25, 13.15, -4.36, -4.73; IR (thin film) ν 3028 (w), 2954 (m), 2929 (m), 2896 (w), 
2856 (m), 1718 (s), 1656 (w), 1456 (m), 1366 (m), 1340 (m), 1293 (w), 1259 (s), 
1192 (m), 1164 (s), 1136 (m), 1092 (m), 1032 (m); [α]24D = -100 (c = 0.68, 
CH2Cl2); MS (ESI) calculated for C26H39NO4S2Si  [M+H]+: 521.21, found 521.27. 
 
 
A solution of the enoate (0.516 g, 0.989 mmol) was dissolved in CH2Cl2 
(19 mL) and cooled to -70 °C.  diisobutylaluminum h ydride (~6 mL, 1 M) was 
added until the yellow color of the solution ceased to persist.  The reaction was 
immediately quenched with aqueous sodium potassium tartrate (15 mL) and 
stirred vigorously at rt for 2 h.  The reaction mixture was diluted with brine (20 
mL) and extracted with CH2Cl2 (3 x 30 mL).  The combined organics were dried 
over sodium sulfate, concentrated en vaccuo and purified via column 
chromatography (20%→30% EtOAc/hexanes) to yield 0.196 g of the aldehyde 
(0.722 mmol, 73%) as a colorless oil. 
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To a solution of the allylic alcohol (0.943 g, 3.46 mmol) in CH2Cl2 (30 mL) 
was added freshly distilled acetic anhydride (1.64 mL, 17.3) and pyridine (1.96 
mL, 24.2 mmol).  The reaction mixture was stirred overnight then quenched with 
10% HCl (10 mL), extracted with CH2Cl2 (2 x 20 mL) the combined organics were 
then washed with saturated aqueous sodium bicarbonate (30 mL) and the 
aqueous phase was washed with CH2Cl2 (2 x 20 mL).  The combined organics 
were then dried over sodium sulfate, concentrated en vaccuo and purified via 
column chromatography (20% EtOAc/hexanes) to yield 0.967 g of the acetate 
(3.07 mmol, 89%) as a colorless oil.  1H NMR (500 MHz, CDCl3) δ ppm 9.74 (s, 1 
H) 5.67 (m, 2 H) 4.51 (d, J=5.04 Hz, 2 H) 4.18 (br. s., 1 H) 2.45 (br. s., 1 H) 2.29 
(br. s., 2 H) 2.06 (s, 3 H) 1.08 (d, J=6.87 Hz, 3 H) 0.86 (s, 9 H) 0.04 (d, J=12.60 
Hz, 6 H); 13C NMR (126 MHz, CDCl3) δ ppm 204.86, 170.77, 131.13, 127.25, 
71.36, 64.72, 51.02, 37.87, 25.70, 20.95, 17.99, 7.69, -4.25, -4.74; IR (thin film) ν 
2958 (m), 2931 (m), 2892 (w), 2857 (m), 2709 (w), 1742 (s), 1462 (w), 1362 (w), 
1231 (s), 1104 (m), 1031 (m); [α]24D = -6.7 (c = 0.30, CH2Cl2); MS (ESI) 
calculated for C16H30O4Si [M+H]+: 314.19, found 314.16. 
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A solution of (+)-diisopinocampheylborane (1.98 g, 6.95 mmol) was 
dissolved in ether (3.55 mL) and cooled to 0 °C the n methanol (0.282 mL, 6.95 
mmol) was added dropwise, while monitoring the internal temperature so as not 
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to allow the solution temperature to rise above 5 °C.  The reaction mixture was 
stirred for 2 h then a solution of allylmagnesium bromide (6.95 mL, 1M) was 
added dropwise followed by stirring for 1 h at rt.  The reaction mixture was then 
cooled to -70 °C and a solution of the aldehyde (0. 967 g, 3.07 mmol) in diethyl 
ether (3 mL) was added dropwise and stirred for an additional 3 h.  After 
confirming that the reaction was complete by the absence of an aldehyde peak in 
a crude NMR of the reaction mixture, aqueous sodium hydroxide (3 mL, 3 M) and 
aqueous hydrogen peroxide (6 mL, 30%) were added and the biphasic mixture 
was vigorously stirred under reflux for 3 h.  The reaction mixture was diluted with 
ether (20 mL) and brine (20 mL) and the phases separated.  The aqueous phase 
was extracted with ether (2 x 20 mL) and dried over magnesium sulfate, the 
solvent removed and stirred overnight in methanol (20 mL) with potassium 
carbonate (10 mg) to hydrolyze any remaining acetate.  The reaction mixture was 
diluted with brine (20 mL) and CH2Cl2 (20 mL).  After separating the phases the 
aqueous phase was extracted with CH2Cl2 (5 x 20 mL) and the combined 
organics were dried over sodium sulfate, concentrated en vaccuo and purified via 
column chromatography (10% EtOAc/hexanes) to yield 0.833 g of the diol (2.64 
mmol, 86%) as a colorless oil.  1H NMR (500 MHz, CDCl3) δ ppm 5.80 (m, 1 H) 
5.68 (m, 1 H) 5.57 (ddd, J=14.84, 7.27, 6.99 Hz, 1 H) 5.09 (m, 2 H) 4.09 (d, 
J=3.89 Hz, 2 H) 3.86 (br. s., 1 H) 3.79 (br. s., 1 H) 2.61 (br. s., 1 H) 2.27 (m, 3 H) 
2.20 (m, 1 H) 1.59 (d, J=3.67 Hz, 1 H) 1.47 (br. s., 1 H) 0.90 (m, 12 H) 0.09 (s, 6 
H); 13C NMR (126 MHz, CDCl3) δ ppm 135.38, 131.72, 128.18, 117.27, 76.53, 
73.79, 63.47, 39.79, 39.50, 37.83, 25.81, 17.98, 6.08, -3.73, -4.62; IR (thin film) ν 
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3357 (br), 3076 (w), 2954 (s), 2930 (s), 2892 (m), 2858 (s), 1641 (w), 1462 (m), 
1439 (m), 1362 (m), 1255 (m), 1090 (s); [α]23D = +20 (c = 0.94, CH2Cl2); MS (ESI) 
calculated for C17H34O3Si [M+H]+: 314.23, found 314.27. 
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To a solution of titanium IV isopropoxide (0.941 mL, 3.18 mmol) in CH2Cl2 
(10 mL) cooled to -70 °C was added (+)-diethyl tart rate (0.653 mL, 3.82 mmol).  
After stirring for 15 min a solution of the allylic alcohol (1.00 g, 3.18 mmol) in 
CH2Cl2 (3 mL) was added dropwise and stirred for 15 min.  A solution of 
anhydrous tert-butylhydroperoxide in CH2Cl2 (3.18 mL, 3 M) pre-cooled to -20 °C 
was added slowly and the reaction mixture was allowed to warm slowly to 0 °C 
and stir overnight.  The reaction mixture was then poured into a solution of iron II 
sulfate heptahydrate (2.78 g, 10 mmol) and (+)-tartaric acid (0.900 g, 6 mmol) in 
water (10 mL) cooled to 0 °C.  Once the solution ce ased effervescing the 0 °C 
bath was removed and the reaction mixture was vigorously stirred for 0.5 h.  To 
the heterogeneous mixture was added water (10 mL) and CH2Cl2 (10 mL) and 
the phases were separated.  The aqueous phase was extracted with CH2Cl2 (5 x 
20 mL) while the extractions were monitored by TLC to ensure no product 
remained in the aqueous layer.  The combined organics were dried over 
magnesium sulfate and the solvent removed en vaccuo.  The crude oil was 
dissolved in ether (20 mL) and cooled to 0 °C and a  solution of sodium hydroxide 
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in brine (15 mL, 1M) was added and stirred vigorously for 1 h.  The phases were 
separated and the aqueous layer was extracted with CH2Cl2 (5 x 20 mL) while 
the extractions were monitored by TLC to ensure no product remained in the 
aqueous layer.  The combined organics were dried over magnesium sulfate, 
concentrated en vaccuo, and purified via column chromatography (40% 
EtOAc/hexanes) to yield 0.816 g of an inseparable mixture of diastereomers 
(7.4:1) favoring the desired tetrahydropyran (2.48 mmol, 78%) as a colorless oil.  
1H NMR (500 MHz, CDCl3) δ ppm 5.74 (m, 1 H) 5.04 (m, 2 H) 3.90 (m, 3 H) 3.71 
(br. s., 1 H) 3.67 (br. s., 1 H) 3.55 (br. s., 1 H) 2.83 (d, J=5.73 Hz, 1 H) 2.75 (br. 
s., 1 H) 2.26 (ddd, J=13.80, 6.82, 6.64 Hz, 1 H) 2.04 (m, 1 H) 1.66 (t, J=12.72 Hz, 
1 H) 1.52 (d, J=5.27 Hz, 1 H) 1.38 (d, J=13.52 Hz, 1 H) 0.86 (m, 11 H) 0.02 (br. 
s., 6 H); 13C NMR (126 MHz, CDCl3) δ ppm 134.86, 116.61, 75.09, 73.68, 73.38, 
70.47, 63.75, 38.20, 37.01, 30.22, 25.73, 17.97, 10.68, -4.89, -4.96; IR (thin film) 
ν 3407 (br), 3078 (m), 2954 (s), 2928 (s), 2880 (s), 2858 (s), 2738 (w), 2710 (w), 
1827 (w), 1643 (m), 1471 (m), 1432 (m), 1387 (m), 1361 (m), 1317 (m), 1254 
(m), 1193 (w), 1065 (s); [α]23D = +51 (c = 2.0, CH2Cl2); MS (ESI) calculated for 
C17H34O4Si [M+H]+: 330.22, found 330.19. 
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To a solution of the diol (1.34 g, 4.05 mmol) in CH2Cl2 (16 mL) at rt was 
added 4-dimethylaminopyridine (25 mg, 0.202 mmol) and imidazole (1.10 g, 16.2 
mmol) and chlorotriethylsilane (1.39 mL, 8.29 mmol).  The homogeneous mixture 
was stirred for 2 h then quenched with aqueous ammonium chloride (10 mL) and 
the phases were separated.  The aqueous phase was extracted with CH2Cl2 (2 x 
10 mL) and the combined organics were dried over magnesium sulfate, 
concentrated en vaccuo and purified via column chromatography (1% →2% 
EtOAc/hexanes) to yield 1.80 g of the tetrahydropyran (3.22 mmol, 80%) as a 
pale yellow oil.  1H NMR (400 MHz, CDCl3) δ ppm 5.79 (m, 1 H) 5.03 (m, 2 H) 
3.88 (m, 2 H) 3.76 (ddd, J=11.57, 4.73, 1.96 Hz, 1 H) 3.70 (m, 1 H) 3.59 (dd, 
J=10.11, 5.22 Hz, 1 H) 3.47 (m, 1 H) 2.27 (dt, J=14.02, 7.01 Hz, 1 H) 2.02 (m, 1 
H) 1.68 (m, 1 H) 1.48 (d, J=6.85 Hz, 1 H) 1.40 (d, J=13.69 Hz, 1 H) 0.95 (t, 
J=7.83 Hz, 18 H) 0.87 (m, 12 H) 0.60 (m, 12 H) 0.03 (d, J=1.96 Hz, 6 H); 13C 
NMR (101 MHz, CDCl3) δ ppm 135.75, 115.85, 75.94, 73.41, 72.68, 71.16, 
64.53, 38.33, 37.28, 28.77, 25.81, 18.05, 10.75, 6.95, 6.81, 5.06, 4.34, -4.83, -
4.97; IR (thin film) ν 3078 (w), 2955 (s), 2935 (s), 2911 (s), 2877 (s), 1643 (w), 
1460 (m), 1414 (w), 1378 (w), 1361 (w), 1315 (w), 1254 (m), 1144 (m), 1081 (s); 
[α]21D = +31 (c = 1.4, CH2Cl2); MS (ESI) calculated for C29H64O4Si3 [M+H]+: 
558.40, found 558.38. 
119 
 
O
TESO
Me
TBSO
OTES
H
H
O
O
Me
TBSO
OTES
H
H
 
A solution of DMSO (0.68 mL, 9.59 mmol) in CH2Cl2 (2.3 mL) was cooled 
to -70 °C and to it was added freshly distilled oxa lyl chloride (0.41 mL, 4.79 
mmol) in CH2Cl2 (1.0 mL) dropwise.  The solution was allowed to stir for 15 
minutes then a solution of the silyl ether (0.536 g, 0.959 mmol) in CH2Cl2 (1.0 
mL) was added slowly followed by stirring an additional 15 min at -70 °C.  The 
reaction flask was then placed in a -40 °C bath and  stirred for 1 h before cooling 
again to -70 °C.  Triethylamine (2.41 mL, 17.3 mmol ) was added slowly and the 
reaction was mixture was allowed to warm slowly to rt over 2 h.  The reaction 
was quenched with water (5 mL) and diluted with CH2Cl2 (5 mL).  After the 
phases were separated the aqueous phase was extracted with CH2Cl2 (2 x 5 
mL).  The combined organics were dried over magnesium sulfate, concentrated 
en vaccuo, and purified via column chromatography (1% EtOAc/hexanes) to yield 
0.352 g of the aldehyde (0.795 mmol, 83%) as a colorless oil.  1H NMR (500 
MHz, CDCl3) δ ppm 9.62 (d, J=1.60 Hz, 1 H) 5.76 (m, 1 H) 5.06 (dd, J=17.18, 
1.37 Hz, 1 H) 5.01 (dd, J=10.08, 0.69 Hz, 1 H) 4.03 (ddd, J=11.68, 4.81, 2.06 Hz, 
1 H) 3.98 (dd, J=4.81, 1.37 Hz, 1 H) 3.91 (ddd, J=8.02, 6.30, 2.18 Hz, 1 H) 3.85 
(d, J=2.75 Hz, 1 H) 2.27 (ddd, J=14.09, 7.79, 6.30 Hz, 1 H) 2.01 (dt, J=14.20, 
7.10 Hz, 1 H) 1.79 (ddd, J=13.63, 11.57, 2.29 Hz, 1 H) 1.51 (m, 1 H) 1.28 (m, 1 
H) 0.95 (t, J=7.90 Hz, 10 H) 0.87 (m, 12 H) 0.62 (q, J=7.87 Hz, 6 H) 0.02 (s, 6 H); 
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13C NMR (126 MHz, CDCl3) δ ppm 203.06, 135.20, 116.25, 80.02, 73.87, 73.70, 
70.64, 38.12, 37.00, 29.67, 25.74, 18.00, 10.66, 6.68, 4.74, -4.92; IR (thin film) ν 
3078 (w), 2955 (s), 2930 (s), 2878 (s), 2857 (m), 1738 (m), 1643 (w), 1463 (m), 
1432 (w), 1415 (w), 1381 (w), 1362 (w), 1344 (w), 1255 (m), 1099 (s), 1007 (m); 
[α]24D = +23 (c = 1.1, CH2Cl2); MS (ESI) calculated for C17H34O3Si [M+H]+: 
442.29, found 442.2935. 
I
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To a rapidly stirring 0 °C suspension of CrCl 2 (1.06 g, 8.60 mmol) in THF 
(10 mL) was added a solution of CHI3 (0.745 g, 1.98 mmol) and the aldehyde 
(0.410 g, 1.72 mmol) in THF (5 mL) dropwise.  Additional THF (2 x 1 mL) was 
used to ensure complete transfer.  The reaction mixture was stirred overnight at 
0 °C then quenched with water (10 mL) and diluted w ith diethyl ether (10 mL).  
The phases were separated and the aqueous phase was extracted with diethyl 
ether (3 x 10 mL).  The combined organics were dried over MgSO4 and purified 
via column chromatography (1% EtOAc/hexanes) to yield 0.326 g of the vinyl 
iodide (1.02 mmol, 59%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ δ ppm 
6.57 (dt, J=14.20, 7.10 Hz, 1 H) 6.12 (d, J=14.43 Hz, 1 H) 2.35 (m, 2 H) 2.27 (m, 
2 H) 1.05 (m, 21 H); 13C NMR (126 MHz, CDCl3) δ ppm 144.35, 107.02, 81.70, 
76.15, 35.22, 30.30, 18.62, 11.21; IR (thin film) ν 2942 (s), 2865 (s), 2172 (m), 
1608 (w), 1463 (m), 1383 (w), 1365 (w), 1333 (w), 1221 (w), 1147 (w), 1070 (w), 
1037 (w); MS (ESI) calculated for C17H34O3Si [M+H]+: 362.09, found 362.05. 
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To a solution of the vinyl iodide (34 mg, 0.107 mmol) in THF (0.20 mL) 
cooled to -70 °C was added a solution of tert-butyllithium in pentane (0.13 mL, 
0.13 mmol) dropwise.  After stirring for 1.5 h a solution of dimethyl zinc in 
heptane (0.16 mL, 0.16 mL) was added dropwise and stirred for an additional 15 
min at -70 °C.  A solution of the aldehyde (15.8 mg , 0.0357 mmol) in THF (0.10 
mL) was then added dropwise and the reaction was stirred for 3 h followed by 
quenching with aqueous ammonium chloride (1 mL) and dilution with diethyl 
ether (1 mL).  The phases were separated and the aqueous phase was extracted 
with diethyl ether (3 x 1 mL).  The combined organics were dried over 
magnesium sulfate, concentrated en vaccuo, and purified via column 
chromatography (2% EtOAc/hexanes) to yield 16.5 mg of the allylic alcohol 
(0.0243 mmol, 68%) as a colorless oil.  1H NMR (400 MHz, CDCl3) δ ppm 5.77 
(m, 2 H) 5.56 (dd, J=15.49, 7.01 Hz, 1 H) 5.05 (m, 2 H) 4.12 (t, J=5.71 Hz, 1 H) 
3.90 (m, 1 H) 3.83 (d, J=2.28 Hz, 1 H) 3.79 (dt, J=10.35, 3.14 Hz, 1 H) 3.55 (t, 
J=5.71 Hz, 1 H) 2.96 (br. s., 1 H) 2.26 (m, 5 H) 2.02 (m, 1 H) 1.60 (m, 2 H) 1.49 
(d, J=7.17 Hz, 1 H) 1.03 (m, 22 H) 0.94 (m, 9 H) 0.87 (m, 11 H) 0.61 (q, J=8.04 
Hz, 6 H) 0.03 (d, J=3.59 Hz, 6 H); 13C NMR (101 MHz, CDCl3) δ ppm 135.37, 
131.39, 130.23, 116.55, 108.37, 80.40, 77.15, 75.51, 74.81, 73.79, 70.84, 38.41, 
37.27, 32.15, 30.64, 25.74, 19.95, 18.60, 18.00, 11.26, 10.81, 6.94, 5.24, -4.94, -
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4.96; IR (thin film) ν 3475 (br), 2954 (s), 2865 (s), 2359 (w), 2172 (m), 1644 (w), 
1463 (m), 1384 (m), 1361 (m), 1253 (m), 1071 (s), 1005 (m); [α]22D = +4.3 (c = 
0.38, CH2Cl2); MS (ESI) calculated for C38H74O4Si3 [M+H]+: 678.49, found 678.46. 
 
 
The allylic alcohol (0.252 g, 0.371 mmol) was dissolved in MeOH:THF 
(4:1, 5 mL) and PPTS (9.3 mg, 0.0371 mmol) was added.  The reaction mixture 
was allowed to stir overnight followed by quenching with NaHCO3(aq) (2 mL) and 
addition of CH2Cl2.  The phases were separated and the aqueous phase was 
extracted with CH2Cl2 (3 x 5 mL).  The combined organics were dried over 
MgSO4, concentrated en vaccuo, and taken on without purification.  For 
characterization the crude oil could be purified via column chromatography (20% 
EtOAc/hexanes).  1H NMR (500 MHz, CDCl3) δ ppm 5.84 (m, 1 H) 5.76 (m, 1 H) 
5.55 (dd, J=15.58, 7.56 Hz, 1 H) 5.08 (m, 2 H) 4.12 (t, J=7.22 Hz, 1 H) 3.99 (m, 1 
H) 3.86 (m, 2 H) 3.66 (s, 1 H) 3.28 (m, 1 H) 2.30 (m, 5 H) 2.05 (d, J=13.75 Hz, 1 
H) 1.93 (br. s., 1 H) 1.71 (m, 1 H) 1.63 (m, 1 H) 1.53 (d, J=7.10 Hz, 1 H) 1.02 (m, 
20 H) 0.89 (s, 12 H) 0.04 (d, J=4.58 Hz, 6 H); 13C NMR (126 MHz, CDCl3) δ ppm 
135.11, 133.58, 130.40, 117.06, 108.10, 80.96, 76.56, 76.30, 74.06, 73.68, 
70.46, 38.59, 37.26, 31.78, 31.28, 25.79, 19.98, 18.61, 18.04, 11.23, 10.83, -
4.84, -4.96; IR (thin film) ν 3419 (br), 3078 (w), 2942 (s), 2892 (s), 2865 (s), 2172 
(m), 1643 (w), 1463 (m), 1430 (m), 1384 (m), 1362 (m), 1254 (m), 1069 (s); [α]20D 
O
HO
Me
TBSO
OTES
H
H
TIPS
O
HO
Me
TBSO
OH
H
H
TIPS
123 
 
= -10 (c = 1.7, CH2Cl2); MS (ESI) calculated for C32H60O4Si2 [M+H]+: 564.40, 
found 564.38. 
 
 
 
 
To a solution of the crude diol in 2,2-dimethoxypropane (8 mL) was added 
PPTS (10 mg, 0.0398 mmol) and let stir overnight.  The reaction was quenched 
with NaHCO3(aq) (5 mL), diluted with water (10 mL) and CH2Cl2 (10 mL), and the 
phases were separated.  The aqueous phase was extracted with CH2Cl2 (3 x 10 
mL) and the combined organics were dried over MgSO4.  After removal of solvent 
en vaccuo, the crude oil was purified via column chromatography (20% 
EtOAc/hexanes) to yield 0.209 g of the acetonide (0.345 mmol, 93% over 2 
steps) as a colorless oil.  1H NMR (500 MHz, CDCl3) δ ppm 5.89 (m, 1 H) 5.77 
(m, 1 H) 5.61 (dd, J=15.24, 7.68 Hz, 1 H) 5.04 (m, 2 H) 4.61 (t, J=6.64 Hz, 1 H) 
3.93 (dd, J=7.90, 6.30 Hz, 1 H) 3.81 (m, 3 H) 2.32 (m, 4 H) 2.23 (m, 1 H) 2.01 (m, 
1 H) 1.61 (m, 2 H) 1.50 (d, J=6.87 Hz, 1 H) 1.42 (s, 3 H) 1.34 (s, 3 H) 1.02 (m, 21 
H) 0.87 (m, 12 H) 0.03 (d, J=3.67 Hz, 6 H); 13C NMR (126 MHz, CDCl3) δ ppm 
135.56, 132.83, 126.32, 116.21, 108.15, 108.08, 80.55, 79.79, 78.65, 73.87, 
70.95, 70.71, 38.50, 37.23, 32.23, 31.05, 27.64, 25.75, 25.47, 20.08, 18.62, 
18.02, 11.23, 10.83, -4.91, -4.93; IR (thin film) ν 3076 (w), 2938 (s), 2892 (s), 
2865 (s), 2913 (w), 2172 (m), 1738 (w), 1671 (w), 1643 (m), 1463 (m), 1432 (m), 
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1380 (m), 1368 (m), 1320 (w), 1254 (m), 1218 (m), 1193 (w), 1165 (w), 1069 (s); 
[α]21D = +53 (c = 2.0, CH2Cl2); MS (ESI) calculated for C35H64O4Si2 [M+H]+: 
604.43, found 604.4343. 
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To a solution of the aldehyde (3.92g, 14.8 mmol) in benzene (50 mL) was 
added the ylide (6.45 g, 17.8 mmol).  The solution was refluxed overnight and 
after cooling to rt the reaction mixture was loaded directly onto a column and 
purified (10% EtOAc/hexanes) to yield 5.00 g of the enoate (14.3 mmol, 97%) as 
a colorless oil.  1H NMR (400 MHz, CDCl3) δ ppm 7.24 (s, 2 H) 6.87 (d, J=8.48 
Hz, 2 H) 6.53 (d, J=10.11 Hz, 1 H) 4.42 (s, 2 H) 4.18 (q, J=7.17 Hz, 2 H) 3.79 (s, 
3 H) 3.41 (t, J=6.52 Hz, 2 H) 2.47 (m, 1 H) 1.83 (s, 3 H) 1.58 (m, J=7.05, 7.05, 
6.93, 6.68 Hz, 2 H) 1.32 (m, 9 H) 0.98 (d, J=6.85 Hz, 3 H); 13C NMR (101 MHz, 
CDCl3) δ ppm 168.29, 158.92, 147.86, 130.57, 129.04, 126.17, 113.55, 72.34, 
69.88, 60.24, 55.06, 36.67, 33.05, 29.56, 27.17, 26.17, 19.90, 14.16, 12.40; IR 
(thin film) ν 2931 (s), 2856 (s), 1710 (s), 1649 (w), 1613 (m), 1586 (w), 1513 (s), 
1463 (m), 1389 (w), 1365 (m), 1301 (m), 1248 (s), 1174 (m), 1136 (w), 1098 (s), 
1037 (m); [α]25D = -21 (c = 1.1, CH2Cl2); MS (ESI) calculated for C21H32O4 [M+H]+: 
348.23, found 348.2379. 
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A solution of the enoate (5.00 g, 14.3 mmol) in CH2Cl2 (150 mL) was 
cooled to -70 °C and a solution of DIBAL-H (57.4 mL , 1 M) was added slowly.  
The reaction mixture was allowed to stir for 15 min followed by quenching with 
aqueous sodium potassium tartrate (75 mL).  The heterogeneous mixture was 
stirred vigorously for 2 h or until the mixture separated into two clear phases 
upon standing.  The phases were separated and the aqueous phase was 
extracted with CH2Cl2 (2 x 30 mL).  The combined organics were dried over 
Na2SO4, concentrated en vaccou, and purified via column chromatography (40% 
EtOAc/hexanes) to yield 4.34 g of the allylic alcohol (14.2 mmol, 99%) as a 
colorless oil.  1H NMR (400 MHz, CDCl3) δ ppm 7.24 (s, 2 H) 6.87 (d, J=7.82 Hz, 
2 H) 5.15 (d, J=9.46 Hz, 1 H) 4.42 (s, 2 H) 3.94 (br. s., 2 H) 3.78 (m, 3 H) 3.41 (t, 
J=6.68 Hz, 2 H) 2.35 (m, 1 H) 1.64 (s, 3 H) 1.58 (m, J=7.05, 7.05, 6.93, 6.68 Hz, 
2 H) 1.26 (m, 6 H) 0.92 (d, J=6.52 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ ppm 
158.85, 133.05, 132.33, 130.47, 129.05, 113.52, 72.25, 69.91, 68.59, 55.03, 
37.29, 31.79, 29.52, 27.11, 26.17, 20.86, 13.68; IR (thin film) ν 3407 (br), 2929 
(s), 2856 (s), 2062 (w), 1998 (w), 1881 (w), 1613 (m), 1586 (w), 1512 (s), 1456 
(m), 1363 (m), 1302 (m), 1248 (s), 1173 (m), 1096 (m), 1036 (m); [α]24D = -7.1 (c 
= 1.1, CH2Cl2); MS (ESI) calculated for C19H30O0 [M+H]+: 306.22, found 306.3. 
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To a solution of the allylic alcohol (4.86 g, 15.9 g) in benzene (160 mL) 
was added MnO2 (85%, 8.11 g, 79.3 mmol).  The heterogeneous mixture was 
stirred under reflux for 0.5 h then cooled completely before being loaded directly 
onto a column and purified (20% EtOAc/hexanes) to yield 4.66 g of the enal (15.3 
mmol, 96%) as a colorless oil.  1H NMR (400 MHz, CDCl3) δ ppm 9.38 (d, J=2.28 
Hz, 1 H) 7.24 (s, 2 H) 6.87 (d, J=8.48 Hz, 2 H) 6.24 (d, J=9.78 Hz, 1 H) 4.42 (s, 2 
H) 3.78 (d, J=3.26 Hz, 3 H) 3.42 (t, J=6.52 Hz, 2 H) 2.67 (m, 1 H) 1.74 (s, 3 H) 
1.58 (m, J=6.89, 6.89, 6.77, 6.52 Hz, 2 H) 1.37 (m, 6 H) 1.05 (m, 3 H); 13C NMR 
(101 MHz, CDCl3) δ ppm 195.34, 160.35, 158.87, 137.71, 130.45, 128.98, 
113.49, 72.28, 69.70, 54.99, 36.40, 33.30, 29.44, 27.06, 26.07, 19.64, 9.17; IR 
(thin film) ν 2931 (s), 2856 (s), 2709 (w), 1686 (s), 1638 (m), 1613 (m), 1586 (w), 
1514 (s), 1456 (m), 1362 (m), 1302 (m), 1248 (s), 1173 (m), 1098 (s), 1036 (s); 
[α]22D = -6.5 (c = 0.92, CH2Cl2); MS (ESI) calculated for C21H32O4 [M+H]+: 304.4, 
found 304.2. 
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A solution of 14.8% allyl methoxymethyl ether in toluene (13.4 g, 19.4 
mmol) was dissolved in THF (10.3 mL) and cooled to -70 °C.  To the stirring 
solution was added 1.3 M sec-butyllithium in cyclohexane (14.0 mL, 18.2 mmol) 
dropwise over 20 min then stirred for 30 min.  A 1 M solution of (+)-B-
methoxydiisopinocampheylborane in ether (18.8 mL, 18.8 mmol) was added over 
20 min then stirred for 1 h at -70 °C followed by d ropwise addition of boron 
trifluoride diethyl etherate (2.46 mL, 19.4 mmol).  A solution of the aldehyde (1.54 
g, 5.06 mmol) in THF (50 mL) was immediately added dropwise.  The reaction 
mixture stirred for 3h at -70 °C then slowly warmed  to rt and stirred overnight.  
After all volatiles were removed en vaccuo, the crude oil was dissolved in ether 
(50 mL) and a solution of 3 N NaOH(aq) (10 mL) and 30% hydrogen peroxide (20 
mL) was added.  The heterogeneous mixture was stirred vigorously under reflux 
for 3 h.  The phases were separated and the aqueous phase was extracted with 
ether (3 x 15 mL).  The combined organics were dried over MgSO4, concentrated 
en vaccuo, and purified via column chromatography (20% EtOAc/hexanes) to 
yield 1.97 g of the allylic alcohol (4.85 mmol, 96%) as a colorless oil.  1H NMR 
(400 MHz, CDCl3) δ ppm 7.24 (m, J=8.48 Hz, 2 H) 6.86 (m, J=8.48 Hz, 2 H) 5.56 
(ddd, J=17.52, 10.19, 7.82 Hz, 1 H) 5.19 (m, 3 H) 4.73 (d, J=6.52 Hz, 1 H) 4.59 
(d, J=6.52 Hz, 1 H) 4.41 (s, 2 H) 3.99 (t, J=7.99 Hz, 1 H) 3.88 (d, J=8.15 Hz, 1 H) 
3.78 (s, 3 H) 3.39 (m, 5 H) 2.86 (br. s., 1 H) 2.33 (m, 1 H) 1.56 (m, 5 H) 1.21 (m, 
6 H) 0.92 (d, J=6.52 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ ppm 158.92, 136.55, 
134.37, 131.08, 130.58, 129.05, 118.89, 113.57, 94.06, 80.10, 79.86, 72.35, 
70.00, 55.61, 55.08, 37.31, 31.86, 29.69, 27.20, 26.18, 20.81, 11.81; IR (thin film) 
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ν 3466 (br), 3075 (w), 2930 (s), 2856 (s), 2787 (w), 2063 (w), 2002 (w), 1881 (w), 
1729 (w), 1613 (m), 1586 (w), 1514 (s), 1463 (m), 1362 (m), 1302 (m), 1248 (s), 
1209 (m), 1173 (m), 1153 (m), 1098 (s), 1035 (s); [α]22D = +53 (c = 0.82, CH2Cl2); 
MS (ESI) calculated for C24H38O5 [M+H]+: 406.27, found 406.3. 
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To the allylic alcohol (0.385 g, 0.947 mmol) in acrolein diethyl acetal (10 
mL) was added PPTS (12 mg) and let stir overnight.  The reaction was quenched 
with NaHCO3(aq) (5 mL) and dilution with brine (20 mL) and CH2Cl2 (20 mL).  The 
phases were separated and the aqueous phase was extracted with CH2Cl2 (3 x 
10 mL).  The combined organics were dried over Na2SO4, concentrated en 
vaccuo, and purified via column chromatography (10→20% EtOAc/hexanes) to 
yield 0.324 g of the mixed acetal (0.660 mmol, 70%) as a mixture of 
diastereomers and as a colorless oil and 0.096 g of the starting material (0.237 
mmol, 25%) as a colorless oil.  1H NMR (500 MHz, CDCl3) δ ppm 7.25 (s, 2 H) 
6.87 (d, J=8.71 Hz, 2 H) 5.84 (m, 1 H) 5.57 (m, 1 H) 5.35 (dd, J=17.41, 1.15 Hz, 
1 H) 5.17 (m, 4 H) 4.88 (m, 1 H) 4.66 (m, 1 H) 4.42 (s, 2 H) 4.13 (m, 1 H) 4.01 (d, 
J=7.79 Hz, 1 H) 3.79 (m, 3 H) 3.61 (m, 1 H) 3.39 (m, 5 H) 2.33 (br. s., 1 H) 1.55 
(m, 2 H) 1.49 (s, 3 H) 1.26 (d, J=9.16 Hz, 5 H) 1.17 (m, 6 H) 0.92 (m, 3 H); 13C 
NMR (126 MHz, CDCl3) δ ppm 159.05, 138.46, 137.11, 135.99, 135.68, 134.76, 
130.72, 129.50, 129.19, 117.86, 117.44, 113.71, 101.78, 97.78, 94.22, 85.06, 
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84.39, 78.65, 78.00, 72.50, 70.15, 61.27, 58.87, 55.51, 55.35, 55.26, 37.32, 
32.06, 31.97, 29.81, 27.37, 26.28, 21.12, 20.92, 15.35, 15.17, 12.29, 12.03; IR 
(thin film) ν 2974 (m), 2930 (s), 2857 (m), 1735 (w), 1613 (m), 1586 (w), 1513 
(m), 1457 (m), 1407 (w), 1371 (w), 1302 (w), 1248 (m), 1211 (w), 1173 (w), 1150 
(m), 1099 (s), 1038 (s); MS (ESI) calculated for C29H46O6 [M+H]+: 490.33, found 
490.40. 
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To a solution of the triene (1.65 g, 3.37 mmol) in degassed benzene (225 
mL) was added Grubbs’ 2nd generation catalyst (0.286 g, 0.337 mmol) and 
refluxed for 4 h.  After cooling completely DMSO (0.2 mL) was added and 
allowed to stir for 4 h.  Most of the solvent (~200 mL) was then removed en 
vaccuo and the black solution was loaded directly on to a column and purified via 
column chromatography (10% EtOAc/hexanes) to yield 0.915 g of the cyclic 
acetal (1.99 mmol, 59%) as a seperable mixture of diastereomers as a colorless 
oil and 0.479 g of a mixture of the starting material and its homodimer (0.978 
mmol, 29%) as a light brown oil.  Top diastereomer: 1H NMR (500 MHz, CDCl3) δ 
ppm 7.26 (d, J=8.71 Hz, 2 H) 6.87 (d, J=8.48 Hz, 2 H) 6.11 (ddd, J=9.97, 5.04, 
1.26 Hz, 1 H) 5.88 (d, J=10.08 Hz, 1 H) 5.36 (d, J=9.39 Hz, 1 H) 5.10 (d, J=0.92 
Hz, 1 H) 4.67 (d, J=6.87 Hz, 1 H) 4.57 (d, J=6.87 Hz, 1 H) 4.42 (m, 2 H) 3.99 (dq, 
J=9.39, 7.10 Hz, 1 H) 3.94 (s, 1 H) 3.88 (m, 1 H) 3.80 (s, 3 H) 3.62 (dq, J=9.39, 
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7.10 Hz, 1 H) 3.42 (t, J=6.64 Hz, 2 H) 3.34 (m, 3 H) 2.40 (d, J=2.52 Hz, 1 H) 1.69 
(s, 3 H) 1.58 (m, 2 H) 1.25 (m, 9 H) 0.94 (d, J=6.64 Hz, 3 H); 13C NMR (126 MHz, 
CDCl3) δ ppm 159.03, 132.59, 131.52, 130.73, 129.96, 129.17, 129.05, 113.69, 
98.07, 95.82, 77.98, 72.47, 70.17, 68.96, 63.74, 55.42, 55.24, 37.45, 31.83, 
29.77, 27.34, 26.36, 20.84, 15.26, 13.62; IR (thin film) ν 2930 (s), 2856 (s), 1613 
(m), 1586 (w), 1513 (s), 1456 (m), 1384 (w), 1324 (w), 1302 (m), 1248 (s), 1210 
(w), 1180 (m), 1149 (m), 1098 (s), 1038 (s); [α]22D = +61 (c = 1.4, CH2Cl2). 
Bottom diastereomer: 1H NMR (500 MHz, CDCl3) δ ppm 7.28 (s, 2 H) 6.88 (d, 
J=8.48 Hz, 2 H) 6.18 (dd, J=9.97, 5.38 Hz, 1 H) 5.97 (dd, J=9.97, 2.86 Hz, 1 H) 
5.42 (d, J=9.62 Hz, 1 H) 5.15 (d, J=2.52 Hz, 1 H) 4.67 (d, J=6.87 Hz, 1 H) 4.58 
(d, J=6.87 Hz, 1 H) 4.43 (s, 2 H) 4.37 (s, 1 H) 3.87 (dd, J=5.27, 1.83 Hz, 1 H) 
3.79 (m, 4 H) 3.58 (m, 1 H) 3.43 (t, J=6.64 Hz, 2 H) 3.35 (s, 3 H) 2.43 (br. s., 1 H) 
1.70 (s, 3 H) 1.59 (m, J=7.07, 7.07, 6.93, 6.64 Hz, 2 H) 1.32 (m, 6 H) 1.22 (t, 
J=7.10 Hz, 3 H) 0.96 (d, J=6.42 Hz, 3 H); 13C NMR (126 MHz, CDCl3) δ ppm 
158.98, 132.27, 130.67, 129.44, 129.12, 128.86, 128.33, 113.63, 95.79, 94.49, 
72.69, 72.43, 70.11, 67.46, 63.81, 55.42, 55.18, 37.45, 31.79, 29.75, 27.34, 
26.30, 20.93, 15.31, 13.87; IR (thin film) ν 2929 (s), 2857 (s), 1613 (m), 1586 (w), 
1513 (s), 1456 (m), 1389 (w), 1363 (w), 1322 (w), 1302 (m), 1248 (s), 1210 (w), 
1173 (m), 1150 (m), 1101 (s), 1039 (s); [α]21D = +140 (c = 2.3, CH2Cl2); MS (ESI) 
calculated for C27H42O6 [M+H]+: 462.30, found 406.2. 
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A solution of the cyclic acetal (0.470 g, 1.02 mmol) in CH2Cl2 (10.2 mL) 
was cooled to -70 °C and boron trifluoride diethyl etherate (1.28 mL, 10.2 mmol) 
was added over 3 min followed by addition of allyl trimethylsilane (1.62 mL, 10.2 
mmol) over 3 min.  The reaction was allowed to stir for 5 min then the dry 
ice/acetone bath was allowed to warm slowly to -50 °C followed by quenching 
with NaHCO3(aq) (5 mL) and diluting with water (10 mL).  The phases were 
separated and the aqueous phase was extracted with CH2Cl2 (3 x 10 mL).  The 
combined organics were dried aver Na2SO4 and concentrated en vaccuo.  The 
crude oil was purified via column chromatography (10% EtOAc/hexanes) to yield 
0.429 g of the dihydropyran (0.935 mmol, 92%) as a colorless oil.  1H NMR (400 
MHz, CDCl3) δ ppm 7.24 (s, 2 H) 6.86 (d, J=7.17 Hz, 2 H) 6.02 (m, 1 H) 5.94 (m, 
1 H) 5.84 (m, 1 H) 5.37 (d, J=9.46 Hz, 1 H) 5.07 (m, 2 H) 4.68 (d, J=6.85 Hz, 1 H) 
4.57 (d, J=6.85 Hz, 1 H) 4.42 (s, 2 H) 4.36 (t, J=6.52 Hz, 1 H) 4.10 (s, 1 H) 3.92 
(d, J=2.93 Hz, 1 H) 3.79 (d, J=2.61 Hz, 3 H) 3.42 (t, J=6.36 Hz, 2 H) 3.33 (d, 
J=1.30 Hz, 3 H) 2.43 (m, 2 H) 2.26 (ddd, J=13.86, 6.85, 6.68 Hz, 1 H) 1.68 (s, 3 
H) 1.58 (m, 2 H) 1.28 (m, 6 H) 0.93 (d, J=6.52 Hz, 3 H); 13C NMR (101 MHz, 
CDCl3) δ ppm 158.92, 134.46, 132.91, 132.56, 130.64, 129.72, 129.04, 124.82, 
116.94, 113.57, 95.60, 74.29, 72.77, 72.34, 70.05, 68.43, 55.31, 55.08, 37.40, 
36.85, 31.77, 29.68, 27.25, 26.24, 20.87, 13.80; IR (thin film) ν 2930 (s), 2855 
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(s), 1640 (w), 1613 (m), 1586 (w), 1513 (s), 1463 (m), 1362 (m), 1302 (m), 1248 
(s), 1173 (m), 1149 (m), 1101 (s), 1040 (s); [α]19D = +79 (c = 0.76, CH2Cl2); MS 
(ESI) calculated for C28H42O5 [M+H]+: 458.30, found 458.2. 
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A solution of the p-methoxybenzyl ether (0.100 g, 0.218 mmol) in CH2Cl2 
(5 mL) was cooled to 0 °C and pH 7 phosphate buffer  (0.25 mL) was added 
followed by 2,3-dichloro-5,6-dicyanobenzoquinone (0.074 g, 0.327 mmol).  After 
1.5 h the reaction was quenched with NaHCO3(aq) (2 mL) and diluted with water 
10 mL and the phases were separated.  The aqueous phase was separated with 
CH2Cl2 (3 x 5 mL) and the combined organics were dried over MgSO4 and 
concentrated en vaccuo.  The crude oil was purified via column chromatography 
(10→50% EtOAc/hexanes) to yield 0.061 g of the alcohol (0.181 mmol, 83%) as 
a colorless oil.  1H NMR (500 MHz, CDCl3) δ ppm 6.02 (m, 1 H) 5.95 (m, 1 H) 
5.84 (m, 1 H) 5.37 (d, J=9.62 Hz, 1 H) 5.08 (m, 2 H) 4.68 (d, J=5.73 Hz, 1 H) 
4.58 (d, J=7.10 Hz, 1 H) 4.37 (br. s., 1 H) 4.11 (br. s., 1 H) 3.93 (d, J=2.29 Hz, 1 
H) 3.62 (br. s., 2 H) 3.34 (d, J=0.92 Hz, 3 H) 2.44 (m, 2 H) 2.27 (ddd, J=13.69, 
7.10, 6.93 Hz, 1 H) 1.68 (s, 3 H) 1.63 (br. s., 1 H) 1.55 (m, 2 H) 1.28 (m, 6 H) 
0.93 (d, J=5.73 Hz, 3 H); 13C NMR (126 MHz, CDCl3) δ ppm 134.58, 133.08, 
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132.63, 129.89, 124.86, 117.06, 95.70, 74.37, 72.93, 68.49, 62.98, 55.46, 37.47, 
36.94, 32.76, 31.88, 27.27, 25.84, 20.99, 13.92; IR (thin film) ν 3431 (br), 2928 
(s), 2857 (m), 1640 (w), 1453 (m), 1395 (w), 1212 (w), 1186 (w), 1150 (m), 1104 
(m), 1078 (m), 1044 (s); [α]24D = +54 (c = 0.38, CH2Cl2); MS (ESI) calculated for 
C20H34O4 [M+H]+: 338.25, found 338.25. 
 
 
A solution of the alcohol (61 mg, 0.180 mmol) in CH2Cl2 (3.6 mL) was 
cooled to 0 °C and 2,6-lutidine (0.210 mL, 1.80 mmo l) was added, followed by 
addition of Dess-Martin periodinane (153 mg, 0.360 mmol).  The reaction was let 
stir for 4 h the quenched with NaHCO3(aq) (2 mL) and diluted with water (10 mL) 
and CH2Cl2 (10 mL).  The phases were separated and the aqueous phase was 
extracted with CH2Cl2 (3 x 10 mL).  The combined organics were dried with 
MgSO4 and concentrated en vaccuo.  The crude oil was purified via column 
chromatography (10% EtOAc/hexanes) to yield 0.053 g of the aldehyde (0.158 
mmol, 85%) as a colorless oil.  1H NMR (500 MHz, CDCl3) δ ppm 9.75 (s, 1 H) 
6.03 (m, 1 H) 5.95 (m, 1 H) 5.83 (m, 1 H) 5.37 (d, J=9.39 Hz, 1 H) 5.06 (d, 
J=11.23 Hz, 1 H) 4.68 (d, J=6.64 Hz, 1 H) 4.57 (d, J=6.64 Hz, 1 H) 4.37 (t, 
J=6.99 Hz, 1 H) 4.10 (s, 1 H) 3.93 (dd, J=4.93, 1.95 Hz, 1 H) 3.34 (s, 3 H) 2.43 
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(m, 3 H) 2.29 (m, 2 H) 1.62 (m, 5 H) 1.31 (m, 5 H) 0.94 (d, J=6.64 Hz, 3 H); 13C 
NMR (126 MHz, CDCl3) δ ppm 202.90, 134.58, 133.08, 132.20, 130.00, 124.84, 
117.03, 95.66, 74.22, 72.93, 68.26, 55.45, 43.90, 37.21, 36.91, 31.80, 27.08, 
22.21, 20.96, 13.97; IR (thin film) ν 3076 (w), 3036 (w), 2928 (s), 2718 (w), 1726 
(s), 1640 (w), 1455 (m), 1393 (m), 1352 (m), 1212 (m), 1188 (m), 1150 (s), 1104 
(s), 1080 (s), 1043 (s); [α]24D = +91 (c = 0.69, CH2Cl2); MS (ESI) calculated for 
C20H32O4[M+H]+: 336.23, found 336.20. 
 
 
 To a solution of the aldehyde (0.269 g, 0.799 mmol) in t-BuOH (8.0 
mL) and pH 4 phosphate buffer (4 mL) was added 2-methyl-2-butene (3.20 mL, 
30.2 mmol) and sodium chlorite (0.362 g, 4.00 mmol) and stirred for 2.25 h.  The 
reaction was quenched with NH4Cl(aq) and extracted with EtOAc (5 x 10 mL).  
The combined organics were dried with MgSO4 and concentrated en vaccuo.  
The crude acid was then dissolved in CH2Cl2 (2 mL) and N,N’-diisopropyl-O-t-
butyl isourea (0.573 mL, 2.40 mmol) was added.  After stirring for 24 h additional 
isourea (0.573 mL, 2.40 mmol) was added and stirred for 24 h.  The reaction was 
quenched with water (10 mL) and diluted with CH2Cl2 (10 mL) and the phases 
separated.  The aqueous phase was extrated with CH2Cl2 (3 x 10 mL) and the 
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combined organics were dried over MgSO4 and concentrated en vaccuo.  The 
crude oil was purified via column chromatography (10% EtOAc/hexanes) to yield 
0.263 g of the ester (0.647 mmol, 81% over 2 steps) as a colorless oil.  1H NMR 
(500 MHz, CDCl3) δ ppm 6.02 (m, 1 H) 5.93 (m, 1 H) 5.82 (m, J=17.04, 10.05, 
7.07, 7.07 Hz, 1 H) 5.36 (d, J=9.62 Hz, 1 H) 5.05 (m, 1 H) 4.67 (d, J=6.87 Hz, 1 
H) 4.56 (d, J=6.87 Hz, 1 H) 4.35 (t, J=6.99 Hz, 1 H) 4.09 (s, 1 H) 3.91 (dd, 
J=5.04, 2.06 Hz, 1 H) 3.32 (s, 3 H) 2.42 (m, 2 H) 2.26 (dt, J=14.03, 7.07 Hz, 1 H) 
2.17 (t, J=7.68 Hz, 2 H) 1.67 (s, 3 H) 1.54 (dq, J=7.33, 7.18 Hz, 2 H) 1.42 (s, 10 
H) 1.27 (m, 4 H) 0.92 (d, J=6.64 Hz, 3 H); 13C NMR (126 MHz, CDCl3) δ ppm 
173.21, 134.53, 133.02, 132.39, 129.86, 124.84, 117.03, 95.65, 79.80, 74.28, 
72.88, 68.34, 55.41, 37.14, 36.95, 35.59, 31.77, 28.06, 26.97, 25.21, 20.89, 
13.91; IR (thin film) ν 2929 (s), 1730 (s), 1640 (w), 1457 (m), 1392 (m), 1367 (m), 
1255 (m), 1151 (s), 1105 (m), 1044 (s); [α]25D = +187 (c = 1.6, CH2Cl2); MS (ESI) 
calculated for C24H40O5 [M+H]+: 408.29, found 406.2876. 
 
 To a solution of the methoxymethyl ether (50 mg, 0.122 mmol) in 
dry t-butanol (1.2 mL) was added conc. HCl (0.30 mL) and stirred for 1.45 h at rt.  
The reaction was quenched with NaHCO3(aq) and diluted with water (10 mL) and 
diethyl ether (10 mL).  The phases were separated and the aqueous phase was 
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extracted with diethyl ether (3 x 10 mL).  The combined organics were dried over 
MgSO4 and concentrated en vaccuo.  The crude oil was purified via column 
chromatography (10% EtOAc/hexanes) to yield 42 mg of the alcohol (0.115 
mmol, 94%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ ppm 6.08 (m, 1 H) 
5.93 (m, 1 H) 5.84 (m, 1 H) 5.40 (d, J=9.39 Hz, 1 H) 5.09 (m, 2 H) 4.35 (m, 1 H) 
4.09 (s, 1 H) 3.89 (m, 1 H) 2.45 (ddd, J=13.57, 6.70, 6.53 Hz, 2 H) 2.27 (dt, 
J=13.98, 6.99 Hz, 1 H) 2.19 (t, J=7.45 Hz, 2 H) 1.74 (d, J=7.56 Hz, 1 H) 1.67 (s, 
3 H) 1.56 (m, 2 H) 1.43 (s, 9 H) 1.34 (d, J=3.67 Hz, 1 H) 1.26 (br. s., 3 H) 0.95 (d, 
J=6.64 Hz, 3 H); 13C NMR (126 MHz, CDCl3) δ ppm 173.30, 134.50, 132.76, 
132.50, 129.67, 126.53, 117.20, 79.89, 74.01, 73.42, 62.29, 37.17, 36.77, 35.62, 
31.81, 28.09, 26.98, 25.24, 21.25, 14.11; IR (thin film) ν 3445 (br), 3077 (w), 
3034 (w), 2977 (s), 2928 (s), 2866 (m), 1730 (s), 1641 (w), 1456 (m), 1392 (m), 
1367 (m), 1323 (w), 1254 (m), 1155 (s), 1086 (m), 1052 (m); [α]24D = +60 (c = 
0.46, CH2Cl2); MS (ESI) calculated for C22H36O4 [M+H]+: 364.26, found 364.2614. 
 
 
 To a refluxing solution of the bicyclic ether fragment (0.317 g, 
1.18mmol) and Grubbs’ 2nd generation catalyst (0.091 g, 0.107) in CH2Cl2 (3.0 
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mL) was added the THP fragment (0.560 g, 0.926 mmol) in CH2Cl2 (2.5 mL) 
slowly over 4 h via syringe pump.  Solvent was removed en vaccuo and the 
crude oil was purified via column chromatography to yield 0.310 g of coupled 
adduct (0.368 mmol, 40%) as a colorless oil, 0.230 g of a mixture of the THP 
fragment starting material and its homodimer (0.380 mmol, 41%), and 0.174 g of 
the bicyclic ether fragment starting material (0.649 mmol, 55%).  1H NMR (500 
MHz, CDCl3) δ ppm 5.89 (m, 1 H) 5.57 (m, 2 H) 5.43 (dd, J=15.24, 7.68 Hz, 1 H) 
4.62 (t, J=6.87 Hz, 1 H) 4.41 (m, 1 H) 4.36 (m, 2 H) 4.25 (d, J=6.64 Hz, 1 H) 4.04 
(m, 1 H) 3.96 (t, J=6.87 Hz, 1 H) 3.81 (m, 4 H) 2.31 (m, 4 H) 2.25 (m, 1 H) 2.10 
(m, 1 H) 2.00 (ddd, J=11.23, 6.76, 2.41 Hz, 1 H) 1.86 (d, J=11.46 Hz, 1 H) 1.65 
(m, 2 H) 1.50 (m, 2 H) 1.43 (s, 3 H) 1.38 (dd, J=9.05, 6.99 Hz, 1 H) 1.34 (s, 3 H) 
1.21 (s, 9 H) 1.03 (m, 21 H) 0.88 (s, 9 H) 0.85 (d, J=6.87 Hz, 6 H) 0.02 (d, J=7.10 
Hz, 6 H); 13C NMR (126 MHz, CDCl3) δ ppm 178.30, 132.73, 131.81, 130.09, 
126.43, 108.19, 108.05, 80.63, 80.36, 79.85, 79.50, 79.06, 78.48, 74.66, 73.18, 
71.29, 70.64, 62.40, 41.47, 38.70, 38.60, 37.65, 35.62, 32.08, 30.85, 27.47, 
27.17, 25.75, 25.35, 20.12, 18.64, 18.02, 15.14, 11.23, 10.52, -4.94; IR (thin film) 
ν 2957 (s), 2934 (s), 2896 (m), 2864 (s), 2171 (w), 1735 (s), 1463 (m), 1380 (w), 
1368 (w), 1284 (w), 1254 (m), 1220 (w), 1146 (s), 1117 (w), 1065 (s); [α]24D = -
5.4 (c = 0.64, CH2Cl2); MS (ESI) calculated for C48H84O8Si2 [M+H]+: 844.57, found 
844.5705. 
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 To a solution of the protected alkyne (50 mg, 0.0593 mmol) in THF 
(0.59 mL) cooled to 0 °C was added 1 M TBAF (0.30 m L, 0.30 mmol) and let stir 
1.5 h.  The reaction was quenched with water (2 mL) and diluted with diethyl 
ether (1 mL).  The phases were separated and the aqueous phase was extracted 
with diethyl ether (3 x 1 mL).  The combined organics were dried over MgSO4 
and concentrated en vaccuo. The crude oil was purified via column 
chromatography (10→30% EtOAc/hexanes) to yield 35 mg of terminal the alkyne 
(0.0508 mmol, 86%) as a colorless oil.  1H NMR (500 MHz, CDCl3) δ ppm 5.85 
(m, 1 H) 5.60 (m, 2 H) 5.43 (dd, J=15.01, 7.22 Hz, 1 H) 4.64 (t, J=6.76 Hz, 1 H) 
4.40 (m, 3 H) 4.26 (d, J=6.42 Hz, 1 H) 4.04 (br. s., 1 H) 3.93 (t, J=7.10 Hz, 1 H) 
3.82 (m, 4 H) 2.28 (m, 4 H) 2.09 (m, 1 H) 2.00 (m, 2 H) 1.87 (d, J=11.68 Hz, 1 H) 
1.61 (m, 5 H) 1.48 (d, J=6.87 Hz, 1 H) 1.44 (s, 3 H) 1.40 (d, J=7.10 Hz, 1 H) 1.34 
(s, 3 H) 1.23 (m, 9 H) 0.86 (m, 15 H) 0.02 (d, J=6.64 Hz, 6 H); 13C NMR (126 
MHz, CDCl3) δ ppm 178.32, 132.14, 131.83, 130.18, 126.83, 108.25, 83.71, 
80.38, 79.83, 79.50, 79.08, 78.54, 74.68, 73.08, 71.12, 70.66, 68.86, 62.46, 
41.49, 38.71, 38.61, 37.78, 35.72, 31.48, 31.11, 27.60, 27.17, 25.78, 25.45, 
18.54, 18.06, 15.16, 10.54, -4.91, -4.94; IR (thin film) ν 3312 (w), 2958 (s), 2931 
(s), 2899 (m), 2876 (m), 2858 (m), 2118 (w), 1732 (s), 1461 (m), 1379 (m), 1369 
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(m), 1285 (m), 1253 (m), 1220 (m), 1146 (s), 1117 (m), 1065 (s); [α]24D = -1.6 (c = 
0.30, CH2Cl2); MS (ESI) calculated for C39H64O8Si [M+H]+: 688.44, found 688.49. 
 
 To a solution of the terminal alkyne (35 mg, 0.0508 mmol) in 
1%EtOAc/hexanes (1 mL) was added quinoline (20 µL, 0.142 mmol) and 
Lindlar’s catalyst (17 mg).  The reaction mixture was then sparged with hydrogen 
gas for 1 min and maintained under a positive pressure with a balloon for 1.5 h.  
The balloon was removed and the reaction mixture was sparged with argon for 1 
minute and purified via column chromatography (10→30% EtOAc/hexanes) to 
yield 33 mg of the terminal olefin (0.0478 mmol, 94%) as a colorless oil.  1H NMR 
(500 MHz, CDCl3) δ ppm 5.82 (m, 2 H) 5.57 (m, 2 H) 5.42 (dd, J=15.12, 7.79 Hz, 
1 H) 4.99 (m, 2 H) 4.62 (t, J=6.87 Hz, 1 H) 4.39 (m, 3 H) 4.26 (d, J=6.64 Hz, 1 H) 
4.04 (td, J=5.73, 2.06 Hz, 1 H) 3.93 (m, 1 H) 3.82 (m, 4 H) 2.25 (m, 1 H) 2.12 (m, 
5 H) 2.01 (ddd, J=11.57, 6.64, 2.41 Hz, 1 H) 1.86 (d, J=11.46 Hz, 1 H) 1.61 (m, 4 
H) 1.48 (d, J=7.33 Hz, 1 H) 1.43 (s, 3 H) 1.39 (dd, J=9.28, 6.99 Hz, 1 H) 1.34 (s, 
3 H) 1.21 (s, 9 H) 0.88 (s, 9 H) 0.85 (d, J=6.42 Hz, 6 H) 0.02 (d, J=7.33 Hz, 6 H); 
13C NMR (126 MHz, CDCl3) δ ppm 178.32, 138.02, 133.93, 131.80, 130.20, 
125.67, 114.84, 108.12, 80.38, 79.83, 79.52, 79.06, 78.77, 74.68, 73.07, 71.16, 
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70.65, 62.43, 41.48, 38.70, 38.60, 37.72, 35.66, 33.38, 31.85, 31.04, 27.59, 
27.17, 25.77, 25.45, 18.04, 15.14, 10.53, -4.91, -4.96; IR (thin film) ν 2958 (s), 
2931 (s), 2898 (m), 2880 (m), 2857 (m), 1734 (s), 1640 (w), 1461 (m), 1379 (m), 
1369 (m), 1285 (m), 1253 (s), 1220 (m), 1147 (s), 1118 (m), 1065 (s); [α]24D = -
2.6 (c = 0.31, CH2Cl2); MS (ESI) calculated for C39H66O8Si [M+H]+: 690.45, found 
690.53. 
 
 To a solution of the pivalate (33 mg, 0.0478 mmol) in CH2Cl2 (0.50 
mL) cooled to 0 °C was added 1 M diisobutylaluminum  hydride (0.24 mL, 0.24 
mmol) dropwise, quenched after 15 min with saturated aqueous Rochelle’s salt 
(0.5 mL), and let stir at rt for 2 h.  The reaction mixture was diluted with water (1 
mL) and CH2Cl2 (1 mL) and the phases were separated.  The aqueous phase 
was extracted with diethyl ether (5 x 1 mL) and the combined organics were dried 
over MgSO4 and concentrated en vaccuo.  The crude oil was purified via column 
chromatography (40% EtOAc/hexanes) to yield 29 mg of the terminal olefin 
(0.0478 mmol, 100%) as a colorless oil.  1H NMR (500 MHz, CDCl3) δ ppm 5.82 
(m, 2 H) 5.56 (m, 2 H) 5.43 (dd, J=15.24, 7.68 Hz, 1 H) 5.00 (m, 2 H) 4.62 (t, 
J=6.87 Hz, 1 H) 4.37 (s, 1 H) 4.27 (d, J=6.64 Hz, 1 H) 4.00 (m, 2 H) 3.87 (m, 6 H) 
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2.25 (m, 1 H) 2.17 (br. s., 3 H) 2.09 (m, 1 H) 2.03 (m, 1 H) 1.86 (d, J=11.68 Hz, 1 
H) 1.80 (dd, J=7.10, 4.12 Hz, 1 H) 1.61 (m, 4 H) 1.49 (m, 1 H) 1.43 (s, 3 H) 1.39 
(dd, J=9.05, 7.22 Hz, 1 H) 1.34 (s, 3 H) 0.86 (m, 15 H) 0.03 (d, J=8.25 Hz, 6 H); 
13C NMR (126 MHz, CDCl3) δ ppm 138.06, 133.81, 131.87, 130.28, 125.76, 
114.85, 108.15, 82.82, 79.83, 79.69, 78.91, 78.75, 74.27, 73.11, 71.18, 70.65, 
60.97, 41.49, 38.79, 37.82, 35.65, 33.42, 31.87, 31.06, 27.60, 25.76, 25.46, 
18.05, 15.20, 10.55, -4.89, -4.96. 
 
 
 To a solution of the primary alcohol (19.7 mg, 0.0325 mmol) in CH2Cl2 
(0.50 mL) was added Dess-Martin periodinane (28 mg, 0.0660 mmol).  After 
stirring for 15 min at rt the reaction was quenched with NaHCO3(aq) (1 mL) and 
diluted with CH2Cl2 and the phases separated.  The aqueous phase was 
extracted with EtOAc (3 x 1 mL) and the combined organics were dried over 
MgSO4 and concentrated en vaccuo and taken on crude. 
 To a suspension of CrCl2 (47.6 mg, 0.388 mmol) in THF (2.0 mL) 
cooled to 0 °C was added a solution of CHI 3 (50.9 mg, 0.129 mmol) and the 
crude aldehyde in THF (0.75 mL) dropwise.  An additional 0.5 mL THF was used 
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to ensure complete transfer.  The reaction was stirred overnight at 0 °C then 
quenched with water (2 mL) and diluted with diethyl ether (2 mL).  The phases 
were separated and the aqueous phase was extracted with diethyl ether (3 x 1 
mL), dried over MgSO4, and concentrated en vaccuo.  The crude oil was purified 
via column chromatography (20% EtOAc/hexanes) to yield 9.4 mg of the E-vinyl 
iodide (0.0129 mmol, 40%) as a colorless oil and 1.0 mg of the Z-vinyl iodide 
(0.00137 mmol, 4%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ ppm 6.83 
(dd, J=14.43, 5.04 Hz, 1 H) 6.56 (dd, J=14.55, 1.72 Hz, 1 H) 5.83 (m, 2 H) 5.55 
(m, 2 H) 5.41 (dd, J=15.47, 7.68 Hz, 1 H) 5.01 (m, 2 H) 4.63 (t, J=6.87 Hz, 1 H) 
4.36 (d, J=1.60 Hz, 1 H) 4.31 (ddd, J=4.81, 2.29, 2.06 Hz, 1 H) 4.27 (d, J=6.19 
Hz, 1 H) 3.93 (m, 1 H) 3.88 (dd, J=9.28, 8.13 Hz, 1 H) 3.82 (m, 3 H) 2.25 (m, 1 H) 
2.16 (m, 3 H) 2.09 (m, 1 H) 1.98 (ddd, J=11.57, 6.42, 2.63 Hz, 1 H) 1.87 (dd, 
J=11.46, 1.15 Hz, 1 H) 1.63 (m, 1 H) 1.56 (m, 2 H) 1.48 (m, 1 H) 1.43 (m, 3 H) 
1.39 (dd, J=9.28, 6.99 Hz, 1 H) 1.34 (m, 3 H) 1.25 (s, 2 H) 0.89 (m, 10 H) 0.85 
(dd, J=6.87, 3.21 Hz, 6 H) 0.03 (d, J=4.58 Hz, 5 H); 13C NMR (126 MHz, CDCl3) 
δ ppm 140.91, 138.04, 133.91, 131.43, 130.46, 125.71, 114.87, 108.14, 83.47, 
79.83, 79.46, 79.40, 78.78, 76.74, 75.58, 73.09, 71.18, 70.65, 41.20, 38.61, 
37.69, 35.58, 33.40, 31.85, 31.06, 27.60, 25.78, 25.47, 18.06, 15.00, 10.52, -
4.88, -4.91. 
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